nit-13 - haryanahealth.nic.inharyanahealth.nic.in/writereaddata/tender/labtenderdocument.pdf ·...

95
Page 1 of 95 DOCUMENT (NOT TRANSFERABLE) Tender Reference No. 16/MMC/HMSCL/Tend./2015-16/3/4-A Last Date for receipt of Tender 11.04.2016 ONLINE TENDER DOCUMENT FOR EMPANELMENT OF ANALYTICAL TESTING LABORATORIES FOR THE ANALYSIS OF ALLOPATHIC & AYUSH DRUGS, SURGICAL AND SUTURE ITEMS Haryana Medical Services Corporation Limited, (A Government of Haryana Undertaking) Bays No 59-62, Sector 2, Panchkula. Phone: 0172-575578 Website: ________________ Bid Price Rs 2500/- Bid Security Rs 10,000

Upload: vukhanh

Post on 01-Jul-2018

229 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 1 of 95

DOCUMENT

(NOT TRANSFERABLE)

Tender Reference No. 16/MMC/HMSCL/Tend./2015-16/3/4-A

Last Date for receipt of Tender 11.04.2016

ONLINE TENDER DOCUMENT FOR

EMPANELMENT OF ANALYTICAL TESTING LABORATORIES

FOR THE ANALYSIS OF

ALLOPATHIC & AYUSH DRUGS, SURGICAL AND SUTURE ITEMS

Haryana Medical Services Corporation Limited,

(A Government of Haryana Undertaking)

Bays No 59-62, Sector 2, Panchkula.

Phone: 0172-575578

Website: ________________

Bid Price – Rs 2500/-

Bid Security – Rs 10,000

Page 2: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 2 of 95

INDEX

S.No. Title Contents Page No

1 Section I Notice Inviting Tender 3-5

2 Section II Schedule of Requirements: Brief description of

testing Drug items,

6-46

3 Section III Eligibility Criteria 47-48

4 Section IV Instruction to Bidders 49-52

5 Section V Bidding Procedure 53-64

6 Section VI Contract Document 65-76

7 Section VII Conditions of Contract 77-84

8 Section VIII Forms and Formats 85-95

Page 3: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 3 of 95

SECTION I: NOTICE INVITING TENDER

Page 4: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 4 of 95

Haryana Medical Services Corporation Limited

(A Government of Haryana Undertaking)

NOTICE INVITING TENDER

Tender Ref. No.: 16/MMC/HMSCL/Tend./2015-16/3/4-A

1. The Haryana Medical Services Corporation Limited - HMSCL is a fully owned Govt.

company set up by the Govt. of Haryana to act as the central procurement agency for

procuring all essential drugs, Ayush drugs, consumables and equipments for various

health care institutions of the State. HMSCL invites online bids from the eligible and

qualified bidders for Online Tender for the Rate Contract of tender documents for

empanelment of analytical testing laboratories for the analysis of allopathic & Ayush

Drugs, Surgical and Suture items

2. Bidding will be conducted through Open Competitive Bidding following a two Bid

System i.e. Technical Bid and Financial Bid as per procedure specified in the tender

document.

3. The Schedule of E-Tendering Activities are as under:

S. No. Activity Date and Time 1 Period of sale of Bidding Document 21.03.2016 onwards

2 Date, time and venue of pre-bid

meeting

04.04.2016 at 11:30 am Conference hall of

Haryana Medical Services Corporation Ltd.

Panchkula.

3 End of Bid Submission 11.04.2016 till 5:00 PM

4 Opening of Technical Bid 12.04.2016 at 12:00 PM in HMSCL Conference

Hall, Sector 2, Panchkula

4. The date and time for opening of the Financial Bids shall be intimated after evaluation of

the technical bid.

5. In case date of opening falls on day which is declared public holiday, the bids shall be

opened on the next day at the same time.

6. Bidders requiring further information or clarification can obtain the same by writing

Page 5: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 5 of 95

email to [email protected].

7. The bidders are advised to register themselves on the e-procurement

portal www.etenders.hry.nic.in and obtain valid Class III Digital Signature Certificate

(DSC) as per Information Technology (IT) Act, 2000. The said website can be accessed for

additional information about registration and use of Portal.

8. Bidders can submit its tender online at www.etenders.hry.nic.in on or before the dates

specified. The Hard copy of the Technical Bid only should also be submitted at the

address below latest by 5:00 PM hrs on 11.04.2016

9. (a) The Bid documents can be viewed at the websites www.etenders.hry.nic.in

www.haryanahealth.nic.in, www.nrhmharyana.gov.in and www.hshrc.gov.in Cost

towards the downloaded Bid documents, should be deposited in the manner as indicated

in the tender document HMSCL will only evaluate bids of bidders who have submitted

the cost of Bid Documents.

(b)The Bidders who have downloaded the Bid documents, shall be solely responsible for

checking the above website for any addendum/amendment to the bid document issued

subsequently , and take into consideration the same while preparing and submitting the

Bids.

(c)All further notifications/amendments, if any, shall only be uploaded on websites

mentioned at 9(a).

10 Bids must be submitted in the manner as specified in the instructions to bidders in the

tender document. Late Bid or Bids not submitted at the designated address will be

summarily rejected. Bidders’s representatives are invited to attend the prebid meeting

and bid opening.

Managing Director,

Haryana Medical Services Corporation Limited

Page 6: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 6 of 95

SECTION II: SCHEDULE OF REQUIREMENTS

Page 7: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 7 of 95

Section II: Schedule of Requirements

1.1 Schedule of Requirements 1.1.1 LIST OF GOODS

DNIT

Sr.No

Drug Name Testing charges per sample for complete analysis

In Figure Rupees in

Words Basic

Rates

Taxes Other

Charges

Total

1 Oxygen (medicinal gas) Inhalation

2 Halothane Inhalation 3% to 5% in

oxygen/Nitrous Oxide. Maint 0.5-1%

(250ml)

3 Ketamine (as hydrochloride) Injection 50

mg /ml,10 ml vial

4 Nitrous oxide Inhalation

5 Thiopentone (Sodium powder) Injection

0.5 g vial

6 Propofol Injection 1% vial (10 mg/ml , 10

ml vial)

7 Isoflurane Inhalation 100ml

8 Sevoflurane Inhalation 30 mg/ml, 1 ml

amp.

9 Bupivacaine (hydrochloride) For epidural

& local anaesthesia Injection 0.5%, 5ml

amp.

10 Bupivaccine heavy 5 mg with Dextrose

Monohydrate 80 mg/ml for Spinal

Anaesthesia Injection 5 mg + 80 mg/ml

,4ml amp.

11 Lignocaine Hydrochloride Jelly Sterile

2%, 30g

12 Lignocaine Hydrochloride Injection 2%,

30 ml vial

13 Lignocaine Hydrochloride Injection

(Heavy) 2%, 2ml vial

14 Lignocaine Hydrochloride + Adrenaline

Injection 2% + Adrenaline 1:80,000 ,30ml

vial

15 Lignocaine Hydrochloride Injection 4% ,

30 ml vial

16 Lignocaine Spray/Viscous 10%

Page 8: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 8 of 95

17 Atropine (sulphate) Injection 0.6 mg/ml, 1

ml ampoule

18 Atropine (sulphate) Injection 0.5 mg/ml,

20 ml ampoule

19 Glycopyrolate Injection 0.2 mg/ml (1 ml

amp)

20 Diazepam Injection 5 mg/ml, 2 ml

ampoule

21 Midazolam Tablet 7.5 mg

22 Midazolam Tablet 15 mg

23 Midazolam Injection 1 mg/ml (5ml)

24 Diclofenac (sodium) Tablet 50 mg

25 Diclofenac (sodium) Injection 25 mg/ml

,3ml amp.

26 Diclofenac (sodium) Gel 1%

27 Diclofenac + Paracetamol Tablet

50mg+325mg

28 Ibuprofen Tablet 200mg

29 Ibuprofen Tablet 400 mg

30 Ibuprofen Oral suspension 100 mg/5 ml

31 Paracetamol Tablet 500 mg

32 Paracetamol Suspension 125 mg/5ml , 60

ml

33 Paracetamol Injection 150 mg/ml, 2 ml

amp.

34 Paracetamol Drops 150 mg/ml

35 Aceclofenac Tablet 100 mg

36 Morphine Sulphate/Hydrochloride Tablet

10 mg

37 Morphine Sulphate/Hydrochloride

Injection 10 mg/ml, 1 ml ampoule

38 Tramadol Hydrochloride Tablet 50 mg

39 Tramadol Hydrochloride Injection 50

mg/ml, 2ml amp.

40 Pentazocine lactate Injection 30 mg/ml, 1

ml amp.

41 Fentanyl Injection 50 mcg/ml (2ml)

42 Pethidine Hydrochloride Injection 50

mg/ml, 1 ml amp.

43 Thiocolchicoside Tablet 4 mg

44 Allopurinol Tablet 100 mg

Page 9: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 9 of 95

45 Hydroxy Chloroquine (Sulfate) Tablet 200

mg

46 Sulfasalazine Tablet 500 mg

47 Methotraxate Tablet 2.5 mg

48 Methotraxate Injection 25mg/ml,2ml vial

49 Azathioprin Tablet 50 mg

50 Cetrizine Tablet 10 mg

51 Cetrizine Suspension 5 mg/5ml, 60ml

52 Cetrizine Drops 10 mg/ ml

53 Chlorpheniramine (maleate) Tablet 4 mg

54 Pheniramine maleate Injection 22.75

mg/ml, 2ml amp.

55 Hydroxyzine Tablet 10 mg

56 Hydroxyzine Tablet 25 mg

57 Dexamethasone (disodium) Injection 4

mg/ml, 2ml amp.

58 Dexamethasone Tablet 0.5 mg

59 Hydrocortisone (sodium succinate

powder) Injection 100 mg vial

60 Prednisolone Tablet 10 mg

61 Prednisolone Tablet 20 mg

62 Prednisolone Suspension 5mg/5ml, 60ml

63 Methyl Prednisolone Injection 1 g vial

64 Adrenaline Injection 1 mg/ml, 1:1000 (1ml

amp)

65 Charcoal activated Tablet 250 mg

66 Charcoal activated Tablet 500 mg

67 Antisnake venom (polyvalent solution)

Injection 10 ml

68 Antisnake venom (polyvalent

solution)(Dry Powder) Injection 10 ml

vial

69 Calcium gluconate * Injection 100 mg/ml,

10 ml amp

70 Naloxone (hydrochloride) Injection 400

mcg,1ml ampoule

71 Pralidoxime (PAM) Injection 1 g vial

72 Disodium Edetate Injection 150 mg/ml, 2

ml amp.

73 Penicillamine Tablet/Capsule 250 mg

74 Deferiprone (Iron Chelator)

Page 10: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 10 of 95

Tablet/Capsule 250 mg

75 Carbamazepine Tablet 100 mg

76 Carbamazepine Tablet 200 mg

77 Carbamazepine Suspension 20 mg/ml

78 Lorazepam Injection 2 mg/ml, 2ml amp.

79 Lorazepam Tablet 1 mg

80 Lorazepam Tablet 2 mg

81 Magnesium sulphate Injection

500mg/ml,1 ml ampoule

82 Phenobarbitone Tablet 30 mg

83 Phenobarbitone Tablet 60 mg

84 Phenobarbitone Suspension 20 mg/ 5 ml

85 Phenobarbitone Injection 200 mg/ ml

86 Phenytoin (sodium) Tablet 100 mg

87 Phenytoin Oral solution 125 mg/5 ml

88 Phenytoin (sodium) Injection 50 mg/ml

89 Sodium valproate/Valproic acid (sodium)

Enteric coated tablet 200 mg

90 Sodium valproate/Valproic acid (sodium)

Enteric coated tablet 500 mg

91 Divalproex Sodium equivalent to

Valproic Acid Tablet 250 mg

92 Divalproex Sodium equivalent to

Valproic Acid Tablet 500 mg

93 Clobazam Tablet 10 mg

94 Albendazole Chewable Tablet 400 mg

95 Albendazole Suspension 200 mg/5 ml,10

ml

96 Amoxicillin (anhydrous) Capsules 250

mg

97 Amoxicillin (anhydrous) Capsules 500

mg

98 Amoxicillin Dispersible Tablet 125 mg

99 Amoxicillin (anhydrous powder) Oral

suspension 125 mg/ 5 ml, 30 ml

100 Amoxicillin + clavulanic acid Tablet 500

mg + 125 mg

101 Amoxicillin + clavulanic acid Injection 1

gm + 200 mg

102 Amoxicillin + clavulanic acid Injection 250

mg +50 mg

Page 11: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 11 of 95

103 Amoxicillin + Pottasium Clavulanate

Dispersible Tablet 200 mg +28.5 mg

104 Amoxicillin + clavulanic acid Suspension

200 mg + 28.5 mg in 5ml

105 Ampicillin (sodium powder) Injection 500

mg

106 Cefixime Tablet 100 mg

107 Cefixime Tablet 200 mg

108 Cefixime Dispersible Tablet 50 mg

109 Cefixime Syrup 50 mg/ 5 ml,30 ml

110 Cefadroxil Syrup 125 mg/ 5 ml, 30 ml

111 Cefadroxil Drops 100 mg/ml

112 Cefotaxime Injection 250 mg

113 Cefotaxime Injection 500 mg

114 Cefotaxime Injection 1 gm

115 Ceftriaxone powder (sodium) Injection

250 mg

116 Ceftriaxone powder (sodium) Injection 1

g vial

117 Benzathine penicillin (powder) Injection

12 lacs IU vial

118 Benzathine Pencilin Injection Powder 24

lacs IU vial

119 Ceftazidime powder (pentahydrate)

Injection 250 mg

120 Ceftazidime powder (pentahydrate)

Injection 1 g vial

121 Amikacin Injection 500 mg/2 ml

122 Amikacin Injection 250 mg/2 ml

123 Amikacin Injection 100 mg,/2 ml

124 Gentamycin (sulphate) Injection 40 mg/

ml, 2ml Amp.

125 Azithromycin Tablet 250 mg

126 Azithromycin Tablet 500 mg

127 Azithromycin Suspension (embonate) 200

mg/5 ml,15ml

128 Levofloxacin Tablet 500 mg

129 Ofloxacin Tablet 200 mg

130 Ciprofloxacin (hydrochloride) Tablet 250

mg

131 Ciprofloxacin (hydrochloride) Tablet 500

Page 12: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 12 of 95

mg

132 Ciprofloxacin Injection IV 200 mg/ 100 ml

133 Doxycycline (hydrochloride) Capsules

100 mg

134 Erythromycin estolate Tablet 500 mg

135 Erythromycin estolate (powder) Oral

suspension 125mg/5ml, 30 ml

136 Sulfamethoxazole + trimethoprim

(Cotrimoxazole) Tablet 100 mg +20 mg

137 Sulfamethoxazole + trimethoprim

(Cotrimoxazole) Tablet 800 mg + 160 mg

138 Metronidazole Tablet 200 mg

139 Metronidazole Tablet 400 mg

140 Metronidazole Injection 500 mg/ 100ml

141 Metronidazole Oral solution 100 mg/5 ml

142 Metronidazole Suspension 200 mg/5

ml,50 ml

143 Fluconazole Capsules 150 mg

144 Fluconazole Capsules 200 mg

145 Fluconazole Dispersible Tablet 50 mg

146 Griseofulvin Tablet 250 mg

147 Acyclovir Tablet 200 mg

148 Acyclovir Tablet 400 mg

149 Tinidazole Tablet 500 mg

150 Ivermectin Tablet 6 mg

151 Ivermectin Tablet 3 mg

152 Flunarazine Tablet 10 mg

153 Propranolol Tablet 10 mg

154 Propranolol Tablet 40 mg

155 Levodopa + Carbidopa Tablet 100 mg + 10

mg

156 Trihexyphenidyl (hydrochloride) Tablet 2

mg

157 Bromocriptine (mesylate) Tablet 2.5 mg

158 Ferrous salt + folic acid (large)

Tablet(enteric coated) Equivalent to 100

mg iron + 500 mcg folic acid

159 Ferrous salt + folic acid ( small)

Tablet(enteric coated) Equivalent to 20

mg iron + 100 mcg folic acid ,

160 Ferrous salt + folic acid Syrup

Page 13: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 13 of 95

Equivalent to 100 mg iron + 500 mcg folic

acid / 5 ml

161 Ferrous salt + folic acid Drops

162 Ferrous salt Tablet Equivalent to 100 mg

elemental iron

163 Sucrose (Fe Sucrose 20mg) Injection 20

mg/ml, 5ml ampoule

164 Ferrous salt (Iron sorbitol citric acid

complex) Injection 100 mg/ml

165 Folic acid Tablet 5mg

166 Warfarin (sodium) Tablet 2 mg

167 Warfarin (sodium) Tablet 5 mg

168 Heparin sodium Injection 5000 IU/ ml

169 Heparin LMW Injection

170 Menadion Sodium Bisulphite (Vitamin K)

Injection 10 mg/ml, 1 ml ampoule

171 Vitamin K Injection 1 mg/0.5 ml water

based single dose

172 Protamine sulphate (Heparin Antagonist)

Injection 10 mg/ml, 5-ml ampoule

173 Plasma Volume Expender Injection 500

ml

174 Glycerine trinitrate (sublingual) Tablet

500 mcg

175 Glycerine trinitrate (SR) Tablet 0.5 mg

176 Glycerine trinitrate (Nitro Glycerine)

Injection 5 mg/ ml

177 Isosorbide mononitrate Tablet 5 mg

178 Isosorbide mononitrate Tablet 20 mg (SR)

179 Isosorbide dinitrate Tablet (sublingual) 5

mg

180 Metoprolol Tablet 25 mg

181 Metoprolol Tablet 50 mg

182 Carvediolol Tablet 3.125 mg

183 Adenosine (Phosphate) Injection 3 mg/ ml

184 Diltiazem Tablet 30 mg

185 Diltiazem Injection 5 mg/ml

186 Amiodarone Tablet 100 mg

187 Verapamil Tablet 40 mg

188 Atenolol Tablet 50 mg

189 Amlodipine Tablet 5 mg

Page 14: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 14 of 95

190 Amlodipine Tablet 10 mg

191 Enalapril Maleate Tablet 5 mg

192 Hydrochlorothiazide Tablet 25 mg

193 Methyldopa Tablet 250 mg

194 Losartan HCL Tablet 50 mg

195 Nifedipine Capsule(Sublingual) 5 mg

196 Nifedipine Tablet (SR) 20 mg

197 Ramipril Tablet 2.5 mg

198 Ramipril Tablet 5 mg

199 Labetolol Injection 20 gm

200 Labetolol Tablet 100 mg

201 Telmisartan HCL Tablet 40 mg

202 Dobutamine Injection 125 mg/5 ml

203 Dopamine (hydrochloride) Injection 40

mg/ ml in 5-ml Ampoule

204 Digoxine Tablet 0.25 mg

205 Acetylsalicylic acid Tablet 75 mg

206 Acetylsalicylic acid Tablet 150 mg

207 Clopidogrel Tablet 75 mg

208 Streptokinase (powder) Injection 1500000

IU

209 Atorvastatin Tablet 10 mg

210 Atorvastatin Tablet 20 mg

211 Tranexanemic Acid Injection 500 mg/5 ml

212 Tranexanemic Acid Tablet 500 mg

213 Mephentermine Injection 30 mg/ml

214 Ethamsylate Tablet 500 mg

215 Ethamsylate Tablet 250 mg

216 Ethamsylate Injection 250 mg/2 ml

217 Clotrimazole Pessaries/ Tablet 200 mg

218 Clotrimazole Cream 2 %

219 Clotrimazole Solution/Mouth paint 1%

w/v, 15 ml

220 Acyclovir Cream 5% w/w,5 gm

221 Clindamycin Gel 1% w/w

222 Clobetasol + Gentamycin Ointment 0.05%

+ 0.1%,5 gm

223 Silver sulfadiazine Cream 1% ,250 gm

224 Framycetin Cream 1%,100 gm

225 Gentian Violet Aqueous solution 0.5%

Page 15: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 15 of 95

226 Benzoyl Per Oxide Gel 2.50%,10 gm

227 Gamma Benzene Hexachloride Cream 1%

,25gm

228 Permethrin Lotion 5%

229 Permethrin (Only for scabies) Cream

5%,30 gm

230 Betamethasone ( Dipropionate ) Cream

0.1 %

231 Fluticasone Cream 0.01%

232 Fluocinolone Acetonide Lotion 0.1 %

233 Calamine lotion Lotion 8 %

234 Povidone iodine Solution 5% ,500 ml

235 Povidone iodine Solution 5% ,5 lts

236 Povidone iodine Ointment 5%,15 gm

237 Povidone iodine Ointment 5%,250gm

238 Povidone iodine Solution 10%, 500 ml

239 Povidone iodine Scrub 7.5%, 500 ml

240 Hydrogen Peroxide Solution 6%

241 Cetrimide Solution 20% conc. for dilution

242 Chlorhexidine Solution 5% conc. for

dilution

243 Chlorhexidine Mouth Wash 0.2% w/v

244 Bleaching powder Powder

245 Glutraldehyde Solution 2 %

246 Potassium permanganate Crystal 100 gm

247 Trichloroacetic Acid Crystal

248 Furosemide Tablet 40 mg

249 Furosemide Injection 10 mg/ml 2-ml

ampoule

250 Mannitol (solution) Injectable 20 %,350 ml

251 Mannitol (solution) Injectable 20 %,100 ml

252 Spironolactone Tablet 25 mg

253 Tamsulosin Hydrochloride Tablet 0.4 mg

254 Dutasteride Tablet 0.5 mg

255 Flavoxate Hydrochloride Tablet 200 mg

256 Disodium Hydrogen Citrate Suspension

1.38 gm/100 ml

257 Sodium Bicarbonate Injection 7.5 %

258 Aluminium hydroxide + magnesium

hydroxide + Simethicone Oral suspension

300 mg+150 mg+40 mg/ 5ml,180 ml

Page 16: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 16 of 95

259 Aluminium hydroxide + magnesium hydroxide +

Simethicone+ magnesium carbonate Tablet 240

mg+100 mg+ 25 mg + 60 mg

260 Ranitidine (hydrochloride) Tablet 150 mg

261 Ranitidine Injection 25 mg/ml in 2-ml

amp

262 Omeprazole Capsules 20 mg

263 Pantoprazole Injection 40 mg

264 Domperidone Tablet 30mg SR

265 Domperidone Tablet 10 mg

266 Domperidone Suspension 1 mg/ ml,30 ml

267 Cinnarizine Tablet 25 mg

268 Metoclopramide (hydrochloride) Tablet

10 mg

269 Metoclopramide (hydrochloride)

Injection 5 mg/ml, 2 ml ampoule

270 Prochlorperazine Injection 12.5 mg/ml,2

ml

271 Ondansetron Tablet 8 mg

272 Ondansetron Injection 2 mg/ml, 2ml amp.

273 Promethazine (hydrochloride) Tablet 25

mg

274 Promethazine (hydrochloride) Elixir or

syrup 5 mg/ 5 ml

275 Promethazine (hydrochloride) Injection

25 mg/ml, 2-ml amp

276 Doxylamine succinate Tablet 10 mg

277 Anti-Haemorrhoidal cream containing

local anaesthetic, astringent and anti-

inflammatory medicines Cream

278 Dicyclomine (hydrochloride) Tablet 10

mg

279 Dicyclomine Oral solution 10mg/5ml

280 Mephenamic Acid + Dicyclomine Tablet

500 mg +20 mg

281 Drotaverine Tablet 80 mg

282 Drotaverine Injection 40 mg/ 2 ml

283 Hyoscine butyl bromide Tablet 10 mg

284 Hyoscine butyl bromide Injection 20 mg/

ml

285 Bisacodyl Tablet 5 mg

Page 17: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 17 of 95

286 Milk of Magnesia +Liquid Paraffin

Suspension 11.25 ml + 3.75 ml/15 ml

287 Glycerine Saline Enema

288 Lactulose Solution 10 mg/15 ml

289 Oral rehydration salts (for solution)

Powder As per IP

290 Oral rehydration salts Powder 200 ml

291 Zinc (sulphate) Tablet 20 mg

292 Biphasic Isophane (R-DNA origin 30/70)

Injection 40 I.U/ml

293 Insulin (soluble) Injection 40 IU/ml in 10

ml vial

294 Intermediate-acting insulin (Lente)

Injection 40 IU/ml in 10 ml vial

295 Metformin (hydrochloride) Tablet 500 mg

296 Metformin (hydrochloride) Tablet 1 gm

SR

297 Glimipride Tablet 1 mg

298 Gliclazide Tablet 40 mg

299 Gliclazide Tablet 80 mg

300 Clomifene (citrate) Tablet 50 mg

301 Medroxyprogesterone acetate Tablet 10

mg

302 Progesterone Tablet 100 mg

303 Norethisterone Tablet 5 mg

304 Mifepristone Tablet 200 mg

305 Levothyroxine Tablet 50 mcg

306 Carbimazole Tablet 5 mg

307 Propylthiouracil Tablet 50 mg

308 Tuberculin, purified protein derivative

(PPD) Injection 2 T.U./0.1 ml

309 Anti-RHO-D Immunoglobulin(Human)

Injection Injection 50 mcg /vial

310 Anti-RHO-D Immunoglobulin(Human)

Injection Injection 150 mcg/Vial

311 Anti-RHO-D Immunoglobulin(Human)

Injection Injection 300mcg/Vial

312 Anti Rabies Immunoglobulin, 300IU/ml

Injection

313 Tetanus vaccine Injection 0.5 ml Amp

314 Anti Rabies vaccine (Chick-

Page 18: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 18 of 95

Embryo/Verocell/Human Diploid) (ID)

Injection 1ml.

315 Anti Rabies vaccine (Chick-

Embryo/Verocell/Human Diploid) (IM)

Injection 0.5ml.

316 Atracurium besylate Injection 10 mg/ ml

317 Succinyl Choline Vial Injection 50 mg/ml

318 Neostigmine (methyl) Injection 500 mcg/

ml in 1 ml amp

319 Vecuronium Injection 2 mg/ml,Dry

Powder

320 Recronium Bromide Injection

321 Pancuronium Injection 2 mg/ ml

322 Chloramphenicol Ointment 1%

323 Ciprofloxacin Drops 0.3 %

324 Ciprofloxacin Ointment 0.3 %

325 Ciprofloxacin + Dexamethasone Eye

Drops 0.3% + 0.1%

326 Tobramycin Eye Drops 0.3% w/v, 5ml

327 Moxifloxacin Eye Drops 0.5% w/v, 5 ml

328 Natamycin Eye Drops 2 %

329 Acylovir Eye Ointment 5%,5 gm

330 Prednisolone (sodium phosphate) Eye

Drops 1%

331 Flurbiprofen Eye Drops 0.03%

332 Flouromethalone Eye Drops 0.1 % w/v

333 Disodium Cromoglycate Ear Drops

334 Acetazolamide Tablet 250mg

335 Pilocarpine (hydrochloride or nitrate) Eye

Drops 2 %

336 Timolol (maleate) Eye Drops 0.5%, 5ml

337 Atropine (sulphate) Eye Drops 1%

338 Atropine (sulphate) Eye Ointment 1%

339 Cyclopentolate Eye Drops 1% w/w

340 Homatropine Eye Drops 1%

341 Tropicamide + Phenylepherine Eye Drops

0.8% + 5%

342 Sodium Carboxymethyl Cellulose Eye

Drops 0.5%w/v

343 Hydroxypropyl mehtylcellulose Injection

2 %

Page 19: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 19 of 95

344 Hyaluronidase Injection 1500 IU/ml

345 Tryptan Blue Dye

346 Xylometazoline Drops 0.05 %

347 Xylometazoline Drops 0.1 %

348 Saline Nasal Drops 0.6%

349 Glycerin Solution 500 gm bottle

350 Ichthamol 10% Solution in Glycerine

351 Paradichlorbenzene 2%, Benzocain 2.7%,

Chlorbutol 5%, Turpentine Oil 15% Ear

Drops

352 Chloremphenicol 5% w/v

+Beclomethasone dipropoinate 0.025%

w/v +Clotrimazole 1% w/v + lignocaine

Hydrochloride 2% w/v HCL Ear Drops

353 Clotrimazole Ear Drops

354 Bromhexine Oral solution 4 mg/5ml

355 Methyl ergometrine Tablet 125 mcg

356 Methyl ergometrine Injection 200 mcg in

1 ml ampoule

357 Oxytocin Injection 5 IU in 1 ml ampoule

358 Carboprost Injection 25 mg/ml (250 micro

gm)

359 Misoprostol Tablet 25 mcg

360 Misoprostol Tablet 200 mcg

361 Dinoprostone Gel 0.5gm, 3gm

362 Isoxsuprine (hydrochloride) Tablet 10 mg

363 Isoxsuprine (hydrochloride) Injection 5

mg/ ml

364 Valethemate Injection 8 mg/ml

365 Chlorpromazine (hydrochloride) Tablet

50 mg

366 Fluphenazine (Decanoate) Injection 25

mg, 1 ml ampoule

367 Haloperidol Tablet 5 mg

368 Haloperidol Injection 5 mg , 1 ml

ampoule

369 Risperidone Tablet 2 mg

370 Olanzapine IP Tablet 5 mg

371 Quetiapine Tablet (SR) 50 mg

372 Aripipralzole Tablet 10 mg

373 Amitriptyline Tablet 10 mg

Page 20: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 20 of 95

374 Fluoxetine (hydrochloride) Capsules 20

mg

375 Imipramine (hydrochloride) Tablet 25 mg

376 Sertraline (SR) Tablet 50 mg

377 Escitalopram Tablet 10 mg

378 Paroxetine (CR) Tablet 25 mg

379 Venlafaxine Capsules 37.5 mg

380 Lithium carbonate Tablet 300 mg

381 Alprazolam Tablet 0.25 mg

382 Alprazolam Tablet 0.5 mg

383 Donepezil Tablet 5 mg

384 Clonazepam Tablet 0.5 mg

385 Bupropion Tablet 150 mg

386 Buprenorphine Tablet 0.4 mg

387 Salbutamol (sulphate) Tablet 2 mg

388 Salbutamol (sulphate) Tablet 4 mg

389 Salbutamol Suspension 2 mg/5 ml

390 Salbutamol- aerosol Inhalation 100

micrograms

391 Salbutamol Nebulizer /Respirator

solution 2.5mg/2.5ml

392 Salbutamol (sulphate) Nebulizer solution

5 mg/ ml

393 Etophylline + Theophylline Tablet 231 mg

+ 69 mg (SR)

394 Etophylline + Theophylline Injection 169.4

mg + 56.6 mg/2 ml

395 Beclomethasone Inhalation (MDI) 200

microgram/ dose

396 Budesonide Nebulizer solution 15 ml vial

397 Ipratropium bromide- aerosol Nebulizer

solution

398 Cough Expectorent (Salbutamol 2 mg +

Bromhexine 4 mg) Syrup Salbutamol 2

mg + Bromhexine 4 mg

399 Cough Expectorant Syrup (Each 5ml

contains Diphen Hydramine IP 14.08mg +

Ammomnium Chloride 138 mg + Sodium

Citrate 57.03mg + Menthol 1.14 mg, 100ml

bottle)

400 Amenophylline Injection 25 mg/ ml, 10 ml

Page 21: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 21 of 95

ampoule

401 Glucose/dextrose (solution) Injectable 5%

isotonic

402 Glucose/dextrose (solution) Injectable

10% isotonic

403 Glucose/dextrose Injectable 25%

404 Glucose with sodium chloride/saline

(solution) Injectable 5% glucose + 0.9%

sodium chloride

405 Isolyte P Injection

406 Potassium chloride (solution) Injectable

11.2% in 20ml

407 Ringer lactate (solution) IV injectable IV

408 Sodium Bicarbonate Injection 7.5 %

409 Sodium chloride (solution) Injectable

0.9% isotonic

410 Sodium chloride (solution) Injectable

0.9% isotonic, 100ml

411 Water for injection Injection 5ml ampoule

412 Ascorbic acid Tablet 500 mg

413 Pyridoxine HCl Tablet 10 mg

414 Vitamin A Suspension 100000 IU/ml

415 Multi Vitamin Syrup Each 5 ml to

contain; Vit A 2500IU, Cholecalciferol

200IU, Thiamine 2mg, Reboflavine 1mg,

Pyridoxine 1mg, Nicotinaminde 15mg,

Ascorbic Acid 50mg ,D-Panthenol 2.5mg,

Cyanocobalamin 1mcg, Citrus

Bioflavonoid Compound 5mg

416 Multi Vitamin Injection

417 Multi Vitamin Drops

418 B-Complex Tablet

419 Vitamin D Drops 4000IU

420 Vitamin D Tablet (Chewable) 60000IU

421 Calcium salts Tablet 500 mg

422 Calcium salts Syrup

423 Artesunate Tablet 50 mg

424 Artesunate Injection 60 mg/ml

425 Artemether Injection 80 mg/ml, 1 ml amp

426 Chloroquine (phosphate) Tablet 150 mg

base

Page 22: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 22 of 95

427 Chloroquine Phosphate Injection 40

mg/ml

428 Chloroquine (Phosphate) Suspension 50

mg/ 5 ml

429 Primaquine (Diphosphate) Tablet 2.5 mg

430 Primaquine (Diphosphate) Tablet 7.5 mg

431 Primaquine (Diphosphate) Tablet 15 mg

432 Quinine (Dihydrochloride) Injection 300

mg/ ml, 2ml ampoule

433 Quinine Sulphate Tablet 300 mg

434 Sulfadoxine + Pyrimethamine Tablet 500

mg + 25 mg

435 Temephos Spray 50%, 5 litres

436 Pyrethrum Spray 2%, 25 litres

437 Malathion Technical Spray 95% contents

250 kg

438 Deltamethrin Spray 2.5% W.P, 25 kg MS

Drums

439 Peg Interferon Alfa 2b for subcutaneous

use Injection 80 mcg per 0.5 ml

440 Peg Interferon Alfa 2b for subcutaneous

use Injection 120 mcg per 0.5 ml

441 Sofosbuvir 400 mg tablet + Ledipasvir 90

mg Tablet

442 Sofosbuvir 400 mg Tablet

443 Daclatasvir 60 mg Tablet

444 Purified Freeze – Dried Human

Coagulation Factor VIII, Virus inactivated

Injection 250 IU

445 Purified Freeze Dried Human

Coagulation Factor IX, Virus inactivated

/ Anti Hemophillic Factor IX Injection

600IU

446 Sanitary Napkin

447 Ferrous salt + folic acid(IFA WIFS)

Tablet(enteric coated) Equivalent to 100

mg iron + 500 mcg folic acid

448 Salt Testing Kit

449 Oseltamivir Tablet 75 mg

450 Oseltamivir Tablet 45 mg

451 Oseltamivir Tablet 30 mg

Page 23: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 23 of 95

452 Oseltamivir syrup (each 1 ml

reconstituted suspension contain 12 mg

Oseltamivir, 75 ml bottle) Syrup

453 PPE Kits

454 N-95 Masks

455 Triple Layer Mask

456 Deferiprone Tablet 500 mg

457 Deferasirox Tablet 500 mg

458 Deferoxamine Injection

459 Cotton Gauze Cloth(1 x 5 Than) 90 cm x

18 mtrs

460 Cotton Bandages(1 X 12 Rolls) 15 cm x 5

mtrs

461 Cotton Bandages(1 X 12 Rolls) 10 cm x 4

mtrs

462 Cotton Bandages(1 X 12 Rolls) 5 cm x 4

mtrs

463 Crape Bandages BP(1 X 10 Rolls) 10 cm X

4.5 mtrs

464 Crape Bandages BP(1 X 10 Rolls) 15 cm X

4.5 mtrs

465 Plaster of Paris Bandages (1 X 10 Rolls) 10

cm X 2.7 mtrs

466 Plaster of Paris Bandages(1 X 10 Rolls) 15

cm X 2.7 mtrs

467 Cotton wool IP 100 gm

468 Cotton wool IP 500 gm

469 Disposable Insulin syringe

470 Disposable syringes 2 ml, (24G)

471 Disposable syringes 5 ml, (23G)

472 Disposable syringes- 10 ml. with needle

473 Disposable syringes 2 ml, (23G)

474 Disposable syringes 1 ml (23G)

475 I.V. Canulas 24

476 I.V. Canulas 22

477 I.V. Canulas 20

478 I.V. Canulas 18

479 I.V.Sets Disposable

480 Blood Filter Set

481 Pedeatrics IV Drip set

482 Spinal Needle 23

Page 24: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 24 of 95

483 Spinal Needle 25

484 Endotrocheal Tube 6.5 Non-cuffed

485 Endotrocheal Tube 7.5 cuffed

486 Endotrocheal Tube 7 for cuffed

487 Endotrocheal Tube 7

488 Endotrocheal Tube 2.5 for uncuffed

489 Endotrocheal Tube 3 for uncuffed

490 Infant feeding tube 6

491 Infant feeding tube 8

492 Ryles tube 16

493 Mucous suction trap

494 Foleys catheter 14

495 Foleys catheter 16

496 Urine bag 2000ml

497 Disposable Surgical Gloves 6.5

498 Disposable Surgical Gloves 7

499 Disposable Surgical Gloves 7.5

500 Examination Gloves (small size)

501 Examination Gloves (medium size)

502 Micropore/Surgical Paper Tape 25mm x

9.1mtr.

503 Micropore/Surgical Paper Tape 50mm x

9.1 mtr.

504 Micropore/Surgical Paper Tape 75mm x

9.1 mtr.

505 Disposable Mask

506 Disposable Cap

507 Disposable Shoe cover

508 Cord Clamp

509 ECG electrodes (Disposable kit)

510 OT Sponges

511 Partially absorbable light weight mesh

polyglecaprone 25 & Polypropylene mesh

6x 11 cm

512 Partially absorbable light weight mesh

polyglecaprone 25 & Polypropylene mesh

15 x 15 cm

513 Formalin Solution 400 ml

514 Carbolic Acid 400 ml

515 Isopropyl alcohol based handwash

Solution 400 ml

Page 25: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 25 of 95

516 Opsite Eye Drape Sheet 70m x 70m

517 Blades for Eye surgery Crescent

518 Blades for Eye surgery Keratones 2.8 m

519 Blades for Eye surgery Side Port 15°

520 Blades for Eye surgery Extension 5.2 mm

521 Medical X-Ray Films(1x50) 8'"x10"

522 Medical X-Ray Films(1x50) 10"x12"

523 Medical X-Ray Films(1x50) 12"x15"

524 Medical X-Ray Films(1x50) 14"x14"

525 Medical X-Ray Films(1x50) 14"x17"

526 Agfa CR film (DT1B)(1x100) 8"x10"

527 Agfa CR film (DT1B)(1x100) 10"x12"

528 Agfa CR film (DT1B)(1x100) 11"x14"

529 Agfa CR film (DT1B)(1x100) 14"x17"

530 Agfa CR film (DT2B)(1x100) 8"x10"

531 Agfa CR film (DT2B)(1x100) 10"x12"

532 Agfa CR film (DT2B)(1x100) 11"x14"

533 Agfa CR film (DT2B)(1x100) 14"x17"

534 Suture Absorbable Surgical Suture USP

(Catgut-Chromic) 76 cm x 30 mm, size 1,

½ Circle R.B. heavy needle

535 Suture Absorbable Surgical Suture USP

(Catgut-Chromic) 76 cm x 30 mm, size1-0,

½ Circle R.B. needle

536 Suture Absorbable Surgical Suture USP

(Catgut-Chromic) 76 cm x 30 mm, size 2-

0, ½ Circle R.B. needle

537 Suture Absorbable Surgical Suture USP

(Synthetic) Polyglactin 910 Braided

Coated with Triclosan Antibaterial 90

cm x 40 mm, size -1, ½ Circle R.B. heavy

needle

538 Suture Absorbable Surgical Suture USP

(Synthetic) Polyglactin 910 Braided

Coated with Triclosan Antibaterial 90

cm x 40 mm, size 1-0, ½ Circle R.B. needle

539 Suture Non-Absorbable Surgical Suture

USP (Braided Silk Black)Sutu

Pack(2x75)size1

540 Suture Non-Absorbable Surgical Suture

USP (Braided Silk Black)Sutu

Page 26: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 26 of 95

Pack(2x75)size1-0

541 Suture Non-Absorbable Surgical Suture

USP (Braided Silk Black) 76 cm x 45 mm,

size -2-0, 3/8 Circle reverse cutting needle

542 Suture Non-Absorbable Surgical Suture

USP (Braided Silk Black) 76 cm x 45mm,

size -1-0, 3/8 Circle reverse cutting needle

543 Suture Non-Absorbable Surgical Suture

USP (Braided Silk Black) 90 cm x 16mm,

size -3-0,3/8 Circle cutting needle

544 Suture Non-Absorbable Surgical Suture

USP (Polypropylene Monofilament

suture) 90cm x 30mm, size -1-0, ½ Circle

Tapper cutting heavy needle

545 Suture Non-Absorbable Surgical Suture

USP (Polypropylene Monofilament

suture) 45 cm x 25 mm, size -3-0, 3/8

Circle cutting needle

546 Suture Non-Absorbable Surgical Suture

USP (Polypropylene Monofilament

suture) 100 cm x 45 mm, size -1, ½ Circle

reverse cutting needle

547 Suture Non-Absorbable Surgical Suture

USP (Polypropylene Monofilament

suture) 70 cm x 40 mm, size -1, ½ Circle

R B heavy needle

548 Suture Non-Absorbable Surgical Suture

USP (Polypropylene Monofilament

suture) 70 cm x 25 mm, size -2-0, ½

Circle Tapper cutting needle

549 Suture Non-Absorbable Surgical Suture

USP (Polypropylene Monofilament

suture) 45 cm x 25 mm, size -3-0, ½

Circle R B needle

550 Suture Non-Absorbable Surgical Suture

USP (Polypropylene Monofilament

suture) 60 cm x 16 mm, size -4-0, 3/8

Circle cutting needle

551 Silver Alloy :- Silver - 68.7 % Fineness-

Should be fine powder of 300 mesh

Amalgam time-Should be 45 sec.

Page 27: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 27 of 95

552 Mercury - Should have minor Polish be

dust free.

553 Eugenol - should be colorless, soluble in

alcohol, with a strong odour

554 Zinc Oxide Powder - Finness of 100 mesh

powder purity of 99.8 % AVG moisutre

content by wt. 0.10%

555 G.P. Point -Uniformly hand rolled,

excellent Radiopacity with Different size

556 Diamond bur for air-rotor hand piece,

No.1, (tapering /round/ straight/flame)

557 Diamond bur for air-rotor hand piece,

No.2, (tapering /round/ straight/flame)

558 Diamond bur for air-rotor hand piece,

No.3, (tapering /round/ straight/flame)

559 Restroative cement Type - II -

(Powder/Liquid), Strontium Based,

radiopaque glass ionomer with high

fluoride release shades pale yellow,

yellow brown, dark gray

560 Light cured universal Restorative cement

- (Powder/Liquid) Strontium based, light

curable Glass ionomer (shades - A2 )

561 Light cured universal Restorative cement

- (Powder/Liquid) Strontium based, light

curable Glass ionomer (shades - A3 )

562 K-Files - Size- 15-40 , Length:-21 mm ,

Should have rubber stopper

563 Size- 45-80, Length:-25 mm, Should have

rubber stopper

564 Reamers files - Size-15-40 , Length :-21

mm, Should have rubber stopper

565 Reamers files , Size- 45-80, Length :-25

mm Should have rubber stopper

566 H-Files , Size-15-40 , Length :-21 mm,

Should have rubber stopper

567 H-Files , Size-45-80, Length :-25 mm

Should have rubber stopper

568 Calcium Hydroxide , Paste System Based

and Catalyst -radiopaque

569 Formocresol Formalin, Cresol Glycerin

Page 28: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 28 of 95

,Formocresol Formalin BP 20% v/v ,

Cresol IP 32% v/v , Glycerin IP QS

570 Matrix Strips,Made from a thin, Strong,

flexible, transparent material such as

Mylar

571 Barbed Broaches , Made of stainless steel,

can be sterilized length > 21

572 Glass Beads for Glass Bead Sterilizer,

Should tolerate temperatures of at least

250C as to effectively destroy all microbes

and spores, can be cleaned by any

cleaning liquid.

573 Plastic Beads

574 Lubricant and cleaner spray for hand

piece

575 Cavity Varnish , Cavity Varnish 5%

sodium Fluoride

576 Articulating Paper Strip, Red/Blue/Green

colored with sufficient thickness double

side

577 Zinc Phosphate Cement , Powder and

Liquid

578 Calcium Hydroxide, Powder

579 Matrix Band Retainer , No. 1

580 Matrix Band Retainer , No.8

581 Matrix Band , No. 1

582 Matrix Band , No. 8

583 Paper Point

Ayurvedic Medicines

584 Abhayarishta 200ml

585 Amritarishta 200 ml

586 Arvindasava 200 ml

587 Arjunarishta/ (Parthadyarishta) 200 ml

588 Ashokarishta 200 ml

589 Ashvagandharishta 200 ml

590 Dashamularishta 200 ml

591 Drakshasava 200 ml

592 Kanakasava 200ml

593 Kumaryasava 200ml

594 Kutajarishta 200ml

Page 29: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 29 of 95

595 Khadirarishta 200ml

596 Lodhrasava(Rodhrasava) 200ml

597 Sarasvatarishta 200ml

598 Usheerasava 200ml

599 Vasakasava 200ml

600 Puga Khand/ Suypari Paka 100gm

601 Saubhagya shunthi Paka 100 gm

602 Dashmula Kwath Churna 1 kg

603 Pathyadi Kwath (Shadanga) Churna 1 kg

604 Punarnavadi Kwaath churna 1 kg

605 Pashanbhedadi Kjwath Churna 1 kg

606 Rasnasaptaka Kashaya Churna 1 kg

607 Varunadi Kwath Churna 1 kg

608 Patoladi Kvatha Churna 1 kg

609 Kanchanara Guggulu 1 kg

610 Lakshadi Guggulu 1 kg

611 Rasna Guggulu 1 kg

612 Simhanada Guggulu 1 kg

613 Saptavinshati Guggulu 1 kg

614 Triphala Guggulu 1 kg

615 Trayodashanga Guggulu 1 kg

616 Punarnava Guggulu 1 kg

617 Yogaraja Guggulu 1 kg

618 Panchatikta Ghrita 1 kg

619 Triphala Ghrita 1 kg

620 Ajamodadi Churna 50 gm

621 Balachaturbhadra Churna 100 gm

622 Dashanasanskar Churna 50 gm

623 Dashanasanskar Churna 100 gm

624 Hingwashtaka Churna 50 gm

625 Hingwashtaka Churna100 gm

626 Pushyanuga Churna 50 gm

627 Pushyanuga Churna 100 gm

628 Panchanimba Churna 50 gm

629 Panchanimba Churna 100gm

630 Sitopaladi Churna 50 gm

631 Sitopaladi Churna 100 gm

632 Sudarhsna Churna 50 gm

633 Sudarhsna Churna 100 gm

634 Talishadya Churna 50 gm

Page 30: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 30 of 95

635 Talishadya Churna 100 gm

636 Trikatu Churna 50 gm

637 Trikatu Churna 100 gm

638 Amalaki Churna 50 gm

639 Amalaki Churna 100 gm

640 Arjuna Churna 50 gm

641 Arjuna Churna 100 gm

642 Ashwagnadha Churan 50 gm

643 Ashwagnadha Churan 100 gm

644 Gokshura Churna 50 gm

645 Gokshura Churna 100 gm

646 Guduchi Churna 50 gm

647 Guduchi Churna 100 gm

648 Haritaki Churna 50 gm

649 Haritaki Churna 100 gm

650 Pippali Churna 50 gm

651 Pippali Churna 100 gm

652 Pippali mool Churna 50 gm

653 Pippali mool Churna 100 gm

654 Punarnava Churna 50 gm

655 Punarnava Churna 100 gm

656 Shunthi Churna 50 gm

657 Shunthi Churna 100 gm

658 Vidanga Churna 50 gm

659 Vidanga Churna 100 gm

660 Yashtimadhu/Madhuyashti/Yashti

Churna 50 gm

661 Yashtimadhu/Madhuyashti/Yashti

Churna 100 gm

662 Bala Taila 5 liters

663 Balashwagandhadi Taila 5 liters

664 Dhanwantar Taila/Dhanwantar Taila

Avarti 5 liters

665 Erimedadi Taila 100 ml

666 Erimedadi Taila 200 ml

667 Erimedadi Taila 500 ml

668 Erimedadi Taila 1000 ml

669 Mahanarayan Taila 5 liters

670 Brihanmasha Taila/Mahamash Tails 100

ml

Page 31: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 31 of 95

671 Brihanmasha Taila/Mahamash Tails 200

ml

672 Brihanmasha Taila/Mahamash Tails 500

ml

673 Brihanmasha Taila/Mahamash Tails 1000

ml

674 Moorivenna Tail 5 liters

675 Narayana Taila 100 ml

676 Narayana Taila 200 ml

677 Narayana Taila 500 ml

678 Narayana Taila 1000 ml

679 Nirgundi Taila 100 ml

680 Nirgundi Taila 1000 ml

681 Prasarini Taila 100 ml

682 Prasarini Taila 200 ml

683 Prasarini Taila 500 ml

684 Prasarini Taila 1000 ml

685 Somaraji Taila/Bakuchi taila 100 ml

686 Somaraji Taila/Bakuchi taila 200 ml

687 Somaraji Taila/Bakuchi taila 500 ml

688 Somaraji Taila/Bakuchi taila 1000ml

689 Kottamchukkadi Lepa Churna 1 kg

690 Kottamchukkadi Lepa Churna 2 kg

691 Dhanvantar Gutika 500gm

692 Dhanvantar Gutika 1000gm

693 Kankayan Gutika 500gm

694 Kankayan Gutika 1000gm

695 Lavangadi Vati 250gm

696 Lavangadi Vati 500gm

697 Lavangadi Vati 1000gm

698 Lahsunadi vati 250gm

699 Lahsunadi vati 500gm

700 Lahsunadi vati 1000gm

701 Prabhakar Vati 500gm

702 Prabhakar Vati 1000gm

703 Rajahpravartini Vati 250gm

704 Rajahpravartini Vati 500gm

705 Rajahpravartini Vati 1000gm

706 Samshamani Vati/Guduchighan Vati

500gm

Page 32: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 32 of 95

707 Samshamani Vati/Guduchighan Vati

1000gm

708 Panchamrita Parpati 50gm

709 Panchamrita Parpati 100gm

710 Akika Pishti 100gm

711 Jaharamohara Bhasma 200 gm

712 Svarnamaksika Bhasma 500 gm

713 Punarnavadi Mandura 500 gm

714 Agnitundi Vati 500 gm

715 Chandramrita Rasa 100gm

716 Gandhak Rasayana 500 gm

717 Laghu Sutashekhara Rasa 100gm

718 Shankha Vati 500 gm

719 Shwasakuthara Rasa 500 gm

720 Smritisagar Rasa 100gm

721 Pradarantaka Lauha 100 gm

722 Saptamrita Lauha 100 gm

Homeopathic Medicines Name of Medicine, Unit or Potency, Unit

723 Abrotanum, 30, 100 ml

724 Abrotanum, 200, 100 ml

725 Aconitum napellus, 6, 100 ml

726 Aconitum napellus, 200, 100 ml

727 Aconitum napellus, 1M, 60 ml

728 Actaea racemosa, 200, 100 ml

729 Aesculus Hippocastanum, 200, 100 ml

730 Agaricus muscarius, 200, 100 ml

731 Allium cepa, 30, 100 ml

732 Allium cepa, 200, 100 ml

733 Aloe socotrina, 200, 100 ml

734 Alumina, 200, 100 ml

735 Ammonium carbonicum, 200, 100 ml

736 Ammonium muriaticum, 200, 100 ml

737 Anacardium orientale, 200, 100 ml

738 Anacardium orientale, 1M, 60 ml

739 Antimonium crudum, 30, 100 ml

740 Antimonium crudum, 200, 100 ml

741 Antimonium tartaricum, 6, 100 ml

742 Antimonium tartaricum, 30, 100 ml

743 Antimonium tartaricum, 200, 100 ml

Page 33: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 33 of 95

744 Apis mellifica, 30, 100 ml

745 Apis mellifica, 200, 100 ml

746 Apocynum cannabinum, 30, 100 ml

747 Apocynum cannabinum, 200, 100 ml

748 Agrentum metallicum, 30, 100 ml

749 Agrentum metallicum, 200, 100 ml

750 Argentum nitricum, 30, 100 ml

751 Argentum nitricum, 200, 100 ml

752 Arnica montana, 30, 100 ml

753 Arnica montana, 200, 100 ml

754 Arnica montana, 1M, 60 ml

755 Arsenicum album, 6, 100 ml

756 Arsenicum album, 200, 100 ml

757 Arsenicum iodatum, 6, 100 ml

758 Arsenicum iodatum, 30, 100 ml

759 Arsenicum iodatum, 200, 100 ml

760 Asafoetida, 3x, 100 ml

761 Asafoetida, 200, 100 ml

762 Abies nigra, 6, 100 ml

763 Abies nigra, 30, 100 ml

764 Aurum metallicum, 30, 100 ml

765 Aurum metallicum, 200, 100 ml

766 Aurum metallicum, 1M, 60 ml

767 Bacillinum, 200, 100 ml

768 Bacillinum, 1M, 60 ml

769 Bacillinum, 30, 100 ml

770 Baryta carbonicum, 30, 100 ml

771 Baryta carbonicum, 200, 100 ml

772 Baryta carbonicum, 1M, 60 ml

773 Baryta muriaticum, 6, 100 ml

774 Belladonna, 30, 100 ml

775 Belladonna, 200, 100 ml

776 Bellis perennis, Q, 30 ml

777 Bellis perennis, 30, 100 ml

778 Benzoic acid, 30, 100 ml

779 Benzoic acid, 200, 100 ml

780 Berberis vulgaris, Q, 30 ml

781 Berberis vulgaris, 30, 100 ml

782 Berberis vulgaris, 200, 100 ml

783 Blatta orientalis, Q, 30 ML

Page 34: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 34 of 95

784 Blatta orientalis, 30, 100 ml

785 Blumea odorata, Q, 30 ml

786 Borax, 30, 100 ml

787 Bovista, 30, 100 ml

788 Bovista, 200, 100 ml

789 Bromium, 30, 100 ml

790 Bryonia alba, 30, 100 ml

791 Carbo vegetabilis, 30, 100 ml

792 Carbo vegetabilis, 200, 100 ml

793 Cactus grandiflorus, Q, 30 ml

794 Cactus grandiflorus, 30, 100 ml

795 Calcarea Carbonica , 30, 100 ml

796 Calcarea Carbonica , 200, 100 ml

797 Calcarea Fluorica, 30, 100 ml

798 Calcarea Fluorica, 200, 100 ml

799 Calcarea phosphoricum, 30, 100 ml

800 Calcarea phosphoricum, 200, 100 ml

801 Calcarea phosphoricum, 1M, 60 ml

802 Calendula officinalis, 30, 100 ml

803 Calendula officinalis, 200, 100 ml

804 Camphora, 6, 100 ml

805 Camphora, 200, 100 ml

806 Cannabis indica, 6, 100 ml

807 Cannabis indica, 30, 100 ml

808 Cantharis, Q, 30 ml

809 Cantharis, 30, 100 ml

810 Cantharis, 200, 100 ml

811 Cantharis, 1M, 60 ml

812 Capsicum, 30, 100 ml

813 Capsicum, 200, 100 ml

814 Carbo animalis, 30, 100 ml

815 Carbo animalis, 200, 100 ml

816 Carbolic acid, 30, 100 ml

817 Carbolic acid, 200, 100 ml

818 Carduus marrianus, Q, 30 ml

819 Carduus marrianus, 6, 100 ml

820 Carduus marrianus, 30, 100 ml

821 carcinosinum, 200, 100 ml

822 carcinosinum, 1M, 60 ml

823 Caulophyllum, 30, 100 ml

Page 35: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 35 of 95

824 Caulophyllum, 200, 100 ml

825 Causticum, 30, 100 ml

826 Causticum, 200, 100 ml

827 Causticum, 1M, 60 ml

828 Cedron, 30, 100 ml

829 Cedron, 200, 100 ml

830 Cephalandra indica, Q, 30 ml

831 Chamomilla, 6, 100 ml

832 Chamomilla, 30, 100 ml

833 Chamomilla, 200, 100 ml

834 Chamomilla, 1M, 60 ml

835 Chelidonium majus, Q, 30 ml

836 Chelidonium majus, 30, 100 ml

837 China officinalis, Q, 30 ml

838 China officinalis, 6, 100 ml

839 China officinalis, 30, 100 ml

840 China officinalis, 200, 100 ml

841 Chininum arsenicosum, 3X, 100 ml

842 Chininum arsenicosum, 6, 100 ml

843 Chininum arsenicosum, 30, 100 ml

844 Chininum sulphuricum, 6, 100 ml

845 Cina, 6, 100 ml

846 Cina, 30, 100 ml

847 Cocculus indicus, 6, 100 ml

848 Cocculus indicus, 30, 100 ml

849 Coffea cruda, 30, 100 ml

850 Coffea cruda, 200, 100 ml

851 Colchicum autumnale, 6, 100 ml

852 Colchicum autumnale, 30, 100 ml

853 Colchicum autumnale, 200, 100 ml

854 Collinsonia canadensis, 30, 100 ml

855 Collinsonia canadensis, 200, 100 ml

856 Collinsonia canadensis, 1M, 60 ml

857 Conium maculatum, 6, 100 ml

858 Conium maculatum, 30, 100 ml

859 Conium maculatum, 200, 100 ml

860 Conium maculatum, 1M, 60 ml

861 Colocynthis, 6, 100 ml

862 Colocynthis, 30, 100 ml

863 Colocynthis, 200, 100 ml

Page 36: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 36 of 95

864 Crataegus, Q, 30 ml

865 Crataegus, 3X, 100 ml

866 Crataegus, 30, 100 ml

867 Crataegus, 200, 100 ml

868 Croton tiglium, 6, 100 ml

869 Croton tiglium, 30, 100 ml

870 Condurango, Q, 30 ml

871 Condurango, 30, 100 ml

872 Condurango, 200, 100 ml

873 Digitalis purpura, 6, 100 ml

874 Digitalis purpura, 30, 100 ml

875 Cioscorea villosa, 6, 100 ml

876 Cioscorea villosa, 30, 100 ml

877 Drosera rotundifolia, 30, 100 ml

878 Drosera rotundifolia, 200, 100 ml

879 Dulcamara, 30, 100 ml

880 Dulcamara, 200, 100 ml

881 Echinacea (ext), Q, 30 ml

882 Echinacea (ext), 6, 100 ml

883 Equisetum hyemnale, 6, 100 ml

884 Equisetum hyemnale, 30, 100 ml

885 Equisetum hyemnale, 200, 100 ml

886 Eupatorium perfoliatum, 30, 100 ml

887 Eupatorium perfoliatum, 200, 100 ml

888 Euphrasia officinalis, 30, 100 ml

889 Euphrasia officinalis, 200, 100 ml

890 Eel serum, 3X, 100 ml

891 Eel serum, 6, 100 ml

892 Eel serum, 30, 100 ml

893 Ferrum metallicum, 200, 100 ml

894 Fluoricum acidum, 30, 100 ml

895 Fluoricum acidum, 200, 100 ml

896 Formica rufa, 6, 100 ml

897 Formica rufa, 30, 100 ml

898 Ficus religiosa, Q, 30 ml

899 Gelsemium sempervirens, 6, 100 ml

900 Gelsemium sempervirens, 30, 100 ml

901 Gelsemium sempervirens, 200, 100 ml

902 Gelsemium sempervirens, 1M, 60 ml

903 Glonoin, 30, 100 ml

Page 37: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 37 of 95

904 Glonoin, 200, 100 ml

905 Graphites, 30, 100 ml

906 Graphites, 200, 100 ml

907 Graphites, 1M, 60 ml

908 Guaiacum, 6, 100 ml

909 Guaiacum, 200, 100 ml

910 Gun powder, 3X, 100 ml

911 Gun powder, 6, 100 ml

912 Gun powder, 200, 100 ml

913 Helleborus niger, 6, 100 ml

914 Helleborus niger, 30, 100 ml

915 Helpar sulphuris calcareum, 6, 100 ml

916 Helpar sulphuris calcareum, 30, 100 ml

917 Helpar sulphuris calcareum, 200, 100 ml

918 Helpar sulphuris calcareum, 1M, 60 ml

919 Hydrastis canadensis, Q, 30 ml

920 Hydrocotyle asiatica, 6, 100 ml

921 Hyoscyamus niger, 200, 100 ml

922 Hypericum perforatum, Q, 30 ml

923 Hypericum perforatum, 30, 100 ml

924 Hypericum perforatum, 200, 100 ml

925 Hypericum perforatum, 1M, 60 ml

926 Heela lave, 3X, 100 ml

927 Heela lave, 6, 100 ml

928 Heela lave, 30, 100 ml

929 Ignatia amara, 30, 100 ml

930 Ignatia amara, 200, 100 ml

931 Ignatia amara, 1M, 60 ml

932 Iodium, 30, 100 ml

933 Iodium, 200, 100 ml

934 Iodium, 1M, 60 ml

935 Ipecacuanha, 6, 100 ml

936 Ipecacuanha, 30, 100 ml

937 Ipecacuanha, 200, 100 ml

938 Iris versicolor, 30, 100 ml

939 Iris versicolor, 200, 100 ml

940 Justicia adhatoda, Q, 30 ml

941 Justicia adhatoda, 30, 100 ml

942 Kali bromatum, 3X, 100 ml

943 Kali bromatum, 6, 100 ml

Page 38: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 38 of 95

944 Kali bromatum, 30, 100 ml

945 Kali bichromicum, 30, 100 ml

946 Kali bichromicum, 200, 100 ml

947 Kali phosphoicum, 30, 100 ml

948 Kali phosphoicum, 200, 100 ml

949 Kali carbonicum, 30, 100 ml

950 Kali carbonicum, 200, 100 ml

951 Kali carbonicum, 1M, 60 ml

952 Kali muriaticum, 30, 100 ml

953 Kali muriaticum, 200, 100 ml

954 Kalmia latifolia, 30, 100 ml

955 Kalmia latifolia, 200, 100 ml

956 Kalmia latifolia, 1M, 60 ml

957 kreosotum ext, Q, 30 ml

958 kreosotum ext, 30, 100 ml

959 kreosotum ext, 200, 100 ml

960 Lac defloratum, 30, 100 ml

961 Lac defloratum, 200, 100 ml

962 Lac defloratum, 1M, 60 ml

963 Lac Caninum, 30, 100 ml

964 Lac Caninum, 200, 100 ml

965 Lachesis, 30, 100 ml

966 Lachesis, 200, 100 ml

967 Lachesis, 1M, 60 ml

968 Lapis albus, 6, 100 ml

969 Lapis albus, 30, 100 ml

970 Ledum palustre, 30, 100 ml

971 Ledum palustre, 200, 100 ml

972 Ledum palustre, 1M, 60 ml

973 Lilium tigrinum, 30, 100 ml

974 Lilium tigrinum, 200, 100 ml

975 Lilium tigrinum, 1M, 60 ml

976 Lobelia inflata, 30, 100 ml

977 Lycopodium clavatum, 30, 100 ml

978 Lycopodium clavatum, 200, 100 ml

979 Lycopodium clavatum, 1M, 60 ml

980 Magnesium carbonicum, 30, 100 ml

981 Magnesium carbonicum, 200, 100 ml

982 Magnesium phosphoricum, 30, 100 ml

983 Magnesium phosphoricum, 200, 100 ml

Page 39: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 39 of 95

984 Magnesium phosphoricum, 1M, 60 ml

985 Medorrhinum, 200, 100 ml

986 Medorrhinum, 1M, 60 ml

987 Mercurius corrosivus, 6, 100 ml

988 Mercurius corrosivus, 30, 100 ml

989 Mercurius corrosivus, 200, 100 ml

990 Mercurius solubills, 6, 100 ml

991 Mercurius solubills, 30, 100 ml

992 Mercurius solubills, 200, 100 ml

993 Mercurius solubills, 1M, 60 ml

994 Mezerum, 30, 100 ml

995 Mezerum, 200, 100 ml

996 Millefolium , Q, 30 ml

997 Millefolium , 30, 100 ml

998 Muriatic acid, 30, 100 ml

999 Muriatic acid, 200, 100 ml

1000 Murex purpura, 30, 100 ml

1001 Murex purpura, 200, 100 ml

1002 Naja tripudians, 30, 100 ml

1003 Naja tripudians, 200, 100 ml

1004 Natrum carbonicum, 30, 100 ml

1005 Natrum carbonicum, 200, 100 ml

1006 Natrum carbonicum, 1M, 60 ml

1007 Natrum muriaticum, 30, 100 ml

1008 Natrum muriaticum, 200, 100 ml

1009 Natrum muriaticum, 1M, 60 ml

1010 Natrum phosphoricum, 30, 100 ml

1011 Natrum sulphuricum, 30, 100 ml

1012 Natrum sulphuricum, 200, 100 ml

1013 Natrum sulphuricum, 1M, 60 ml

1014 Nitric acid, 30, 100 ml

1015 Nitric acid, 200, 100 ml

1016 Nitric acid, 1M, 60 ml

1017 Nux moschata, 30, 100 ml

1018 Nux moschata, 200, 100 ml

1019 Nux vomica, 30, 100 ml

1020 Nux vomica, 200, 100 ml

1021 Nux vomica, 1M, 60 ml

1022 Ocimum canum, 6, 100 ml

1023 Ocimum canum, 30, 100 ml

Page 40: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 40 of 95

1024 Ocimum Sanctum, Q, 30 ml

1025 Oleander, 6, 100 ml

1026 Oleander, 30, 100 ml

1027 Opium, 30, 100 ml

1028 Opium, 200, 100 ml

1029 Passiflora incarnata, Q, 30 ml

1030 Petroleum, 30, 100 ml

1031 Petroleum, 200, 100 ml

1032 Petroleum, 1M, 60 ml

1033 Phosphoric acid, 30, 100 ml

1034 Phosphoric acid, 200, 100 ml

1035 Phosphoric acid, 1M, 60 ml

1036 Phosphorus , 30, 100 ml

1037 Phosphorus , 200, 100 ml

1038 Phosphorus , 1M, 60 ml

1039 Physostigma, 30, 100 ml

1040 Physostigma, 200, 100 ml

1041 Plangago major, 6, 100 ml

1042 Plangago major, 30, 100 ml

1043 Plantinum metallicum, 200, 100 ml

1044 Plantinum metallicum, 1M, 60 ml

1045 Plumbun metallicum, 200, 100 ml

1046 Plumbun metallicum, 1M, 60 ml

1047 Podophyllum peltatum, 6, 100 ml

1048 Podophyllum peltatum, 30, 100 ml

1049 Podophyllum peltatum, 200, 100 ml

1050 Prunus spinosa, 6, 100 ml

1051 Prunus spinosa, 30, 100 ml

1052 Prunus spinosa, 200, 100 ml

1053 Psoinum, 30, 100 ml

1054 Psoinum, 200, 100 ml

1055 Psoinum, 1M, 60 ml

1056 Pulsatilla nigricans, 30, 100 ml

1057 Pulsatilla nigricans, 200, 100 ml

1058 Pulsatilla nigricans, 1M, 60 ml

1059 Pyrogenium, 200, 100 ml

1060 Pyrogenium, 1M, 60 ml

1061 Ranunculus bulbosus, 30, 100 ml

1062 Ranunculus bulbosus, 200, 100 ml

1063 Ratanhia, 6, 100 ml

Page 41: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 41 of 95

1064 Ratanhia, 30, 100 ml

1065 Rauwolfia serpentina, Q, 30 ml

1066 Rauwolfia serpentina, 30, 100 ml

1067 Rhododendron, 30, 100 ml

1068 Rhododendron, 200, 100 ml

1069 Rhus toxicodendron, 6, 100 ml

1070 Rhus toxicodendron, 30, 100 ml

1071 Rhus toxicodendron, 200, 100 ml

1072 Rhus toxicodendron, 1M, 60 ml

1073 Robinia, 6, 100 ml

1074 Robinia, 30, 100 ml

1075 Rumex crispus, 6, 100 ml

1076 Rumex crispus, 30, 100 ml

1077 Ruta graveolens, 30, 100 ml

1078 Ruta graveolens, 200, 100 ml

1079 Sabal serrulata, Q, 30 ml

1080 Sabal serrulata, 6, 100 ml

1081 Sabina, 6, 100 ml

1082 Sabina, 30, 100 ml

1083 Senega, 30, 100 ml

1084 Senega, 200, 100 ml

1085 Sarsaparilla, 30, 100 ml

1086 Secale cornutum, 30, 100 ml

1087 Secale cornutum, 200, 100 ml

1088 Selenium, 30, 100 ml

1089 Selenium, 200, 100 ml

1090 Senecio aureus, Q, 30 ml

1091 Senecio aureus, 6, 100 ml

1092 Sepia, 30, 100 ml

1093 Sepia, 200, 100 ml

1094 Sepia, 1M, 60 ml

1095 Silicea, 30, 100 ml

1096 Silicea, 200, 100 ml

1097 Silicea, 1M, 60 ml

1098 Spigelia anthelmia, 6, 100 ml

1099 Spigelia anthelmia, 30, 100 ml

1100 Spigelia anthelmia, 200, 100 ml

1101 Spongia tosta, 6, 100 ml

1102 Spongia tosta, 30, 100 ml

1103 Spongia tosta, 200, 100 ml

Page 42: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 42 of 95

1104 Staphysagria, 30, 100 ml

1105 Staphysagria, 200, 100 ml

1106 Staphysagria, 1M, 60 ml

1107 Sticta pulmonaria, 6, 100 ml

1108 Sticta pulmonaria, 30, 100 ml

1109 Stramonium, 30, 100 ml

1110 Stramonium, 200, 100 ml

1111 Stramonium, 1M, 60 ml

1112 Sabadilla, 30, 100 ml

1113 Sabadilla, 200, 100 ml

1114 Sulphur, 30, 100 ml

1115 Sulphur, 200, 100 ml

1116 Sulphur, 1M, 60 ml

1117 Sulphuric acid, 6, 100 ml

1118 Sulphuric acid, 30, 100 ml

1119 Syphilinum, 200, 100 ml

1120 Syphilinum, 1M, 60 ml

1121 Syzygium jambolanum, Q, 30 ml

1122 Tabacum, 30, 100 ml

1123 Tabacum, 200, 100 ml

1124 Tarentula cubensis, 6, 100 ml

1125 Tarentula cubensis, 30, 100 ml

1126 Tellurium, 30, 100 ml

1127 Tellurium, 200, 100 ml

1128 Terebinthina, 6, 100 ml

1129 Terebinthina, 30, 100 ml

1130 Terminalia arjuna, 6, 100 ml

1131 Teucrium marum, 30, 100 ml

1132 Teucrium marum, 200, 100 ml

1133 Thuja Occidentalis, Q, 30 ml

1134 Thuja Occidentalis, 30, 100 ml

1135 Thuja Occidentalis, 200, 100 ml

1136 Thuja Occidentalis, 1M, 60 ml

1137 Thyroidinum, 200, 100 ml

1138 Thyroidinum, 1M, 60 ml

1139 Trillium pendulum, Q, 30 ml

1140 Trillium pendulum, 30, 100 ml

1141 Tuberculinum bovinum, 200, 100 ml

1142 Uranium nitricum, 3X, 100 ml

1143 Uranium nitricum, 30, 100 ml

Page 43: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 43 of 95

1144 Urtica urens, Q, 30 ml

1145 Urtica urens, 6, 100 ml

1146 Ustilago maydis, Q, 30 ml

1147 Ustilago maydis, 30, 100 ml

1148 Veratrum album, 6, 100 ml

1149 Veratrum album, 30, 100 ml

1150 Veratrum album, 200, 100 ml

1151 Viburnum opulus, Q, 30 ML

1152 Viburnum opulus, 6, 100 ml

1153 Viburnum opulus, 30, 100 ml

1154 Viburnum opulus, 200, 100 ml

1155 Veratrum viride, 30, 100 ml

1156 Veratrum viride, 200, 100 ml

1157 Viscum album, 6, 100 ml

1158 Vanadium, 6, 100 ml

1159 Wyethia, 6, 100 ml

1160 Wyethia, 30, 100 ml

1161 Wyethia, 200, 100 ml

1162 Zincum metallicum, 200, 100 ml

1163 Zincum metallicum, 1M, 60 ml

1164 Zincum phosphoricum, 200, 100 ml

1165 Zincum phosphoricum, 1M, 60 ml

1166 Calcarea phosphorica, 6x, 20 gm

1167 Calcarea sulphurica, 6x, 20 gm

1168 Ferrum phosphoricum, 6x, 20 gm

1169 Kali muriaticum, 6x, 20 gm

1170 Kali sulphuricum, 6x, 20 gm

1171 Kali phosphoicum, 6x, 20 gm

1172 Magnesium phosphoricum, 6x, 20 gm

1173 Magnesium sulphuricum, 6x, 20 gm

1174 Natrum muriaticum, 6x, 20 gm

1175 Natrum phosphoricum, 6x, 20 gm

1176 Natrum sulphuricum, 6x, 20 gm

1177 Silicea, 6x, 20 gm

1178 Alfalfa tonic, ml, 115 ml

1179 Calendula DP, gm, 20 gm

1180 CSS Drops, ml, 15 ml

1181 Phytolacea B.T, ml, 15 ml

Unani Medicines

Medicine Name, Unit

Page 44: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 44 of 95

1182 Arq-e-Ajeeb, 05 ml

1183 Arq-e-Ajwayin, 200 ml

1184 Arq-e-Gaozaban , 200 ml

1185 Arq-e-Gulab, 50 ml

1186 Arq-e-Kasni, 200 ml

1187 Arq-e-Mako, 200 ml

1188 Habb-e-Azaraqi, 30 pills

1189 Habb-e-Bawaseer Amya, 30 pills

1190 Habb-e-Bukhar, 30 pills

1191 Habb-e-Hindi Zeeqi, 30 pills

1192 Habb-e-Jiryan, 30 pills

1193 Habb-e-Jund, 30 pills

1194 Habb-e-Kabid Naushadri, 30 pills

1195 Habb-e-Mubarak, 30 pills

1196 Habb-e-Mudir, 30 pills

1197 Habb-e-Muqil, 30 pills

1198 Habb-e-Mussafi-e-Khoon, 30 pills

1199 Habb-e-Raal, 30 pills

1200 Habb-e-Rasaut, 30 pills

1201 Habb-e-Shifa, 30 pills

1202 Habb-e-Suranjan, 30 pills

1203 Habb-e-Surfa, 30 pills

1204 Habb-e-Tankar, 30 pills

1205 Habb-e-Tursh Mushtahi, 30 pills

1206 Qurs-e-Deedan, 30 pills

1207 Qurs-e-Ghafis, 30 pills

1208 Qurs-e-Kafoor, 30 tabs

1209 Qurs-e-Mulaiyin, 30 tabs

1210 Kushta-e-Baiza-e-Murgh, 10 gms

1211 Kushta-e-Faulad, 10 gms

1212 Kushta-e-Gaodanti, 10 gms

1213 Kushta-e-Shankh, 10 gms

1214 Kushta-e-Sadaf, 10 gms

1215 Itrifal-e-Kishneezi, 100 gms

1216 Itrifal-e-Shahtra, 100 gms

1217 Itrifal-e-Ustukhuddoos, 100 gms

1218 Itrifal-e-Zamani, 100 gms

1219 Jawarish-e-Amla Sada, 100 gms

1220 Jawarish-e-Bisbasa, 100 gms

1221 Jawarish-e-Kamooni, 100 gms

Page 45: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 45 of 95

1222 Jawarish-e-Shahi, 100 gms

1223 Jawarish-e-Zanjabeel, 100 gms

1224 Khamira Gaozaban Sada, 60 gms

1225 Laooq-e-Khiyarshambar, 100 gms

1226 Laooq-e-Sapistan, 100 gms

1227 Marham Gulabi, 50 gms

1228 Marham -e-Kafoori, 50 gms

1229 Marham-e-Quba, 50 gms

1230 Majoon-e-Arad Khurma, 100 gms

1231 Majoon-e-Azaraqi, 100 gms

1232 Majoon-e-Chobchini, 100 gms

1233 Majoon-e-Flasifa, 100 gms

1234 Majoon-e-Hajr-ul-Yahood, 100 gms

1235 Majoon-e-Ispand Sokhtani, 100 gms

1236 Majoon-e-Jograj Guggal, 100 gms

1237 Majoon-e-Kundur, 100 gms

1238 Majoon-e-Masik-ul-Baul, 100 gms

1239 Majoon-e-Muqawwi-e-Rahem, 100 gms

1240 Majoon-e-Najah, 100 gms

1241 Majoon-e-Nankhwah, 100 gms

1242 Majoon-e-Piyaz, 100 gms

1243 Majoon-e-Rahul Momeneen, 100 gms

1244 Majoon-e-Supari Pak, 100 gms

1245 Majoon-e-Suranjan, 100 gms

1246 Majoon-e-Ushba, 100 gms

1247 Majoon-e-Zabeeb, 100 gms

1248 Raughan-e-Aamla, 50 ml

1249 Raughan-e-Babuna Sada, 50 ml

1250 Raughan-e-Surkh, 50 ml

1251 Raughan-e-Turb, 05 ml

1252 Sufoof-e-Bars, 50 gms

1253 Safoof-e-Chutki, 50 gms

1254 Safoof-e-Namak-e-Shaikur Raees, 50 gms

1255 Sufoof-e-Sailan, 50 gms

1256 Sharbat-e-Anjbar, 200 ml

1257 Sharbat-e-Buzoori Motadil, 200 ml

1258 Sharbat-e-Deenar, 200 ml

1259 Sharbat-e-Faulad, 200 ml

1260 Sharbat-e-Khaksi, 200 ml

1261 Sharbat-e-Sadar, 200 ml

Page 46: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 46 of 95

1262 Sharbat-e-Unnab, 200 ml

1263 Sharbat-e-Zoofa Murrakkab, 200 ml

1264 Banadiq-ul-Bazoor, 30 pills

1265 Sunoon-e-Mukhrij-e-Rutubat, 50 gms

1266 Tiryaq-e-Nazla, 10 gms

1267 Zuroor-e-Qula, 10 gms

Signature :

Designation:

Date: Office Seal :

(* All pages should be signed to the authorized persons.)

Note:-

1. The quantity mentioned is only indicative, it may be increased or decreased as per

requirement of the indenting department.

2. All Terms & Conditions of the rate contract in DNIT would apply.

Page 47: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 47 of 95

SECTION III: ELIGIBILTY CRITERIA

Page 48: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 48 of 95

SECTION III: ELIGIBILITY CRITERIA

a) Only Analytical Laboratories having :-

(i) approval on Form 37 under the Drugs and Cosmetics Rules 1945.

(ii) with three years standing in the analysis of drugs, surgical and suture items

(iii) with an annual turnover of Rs.25 Lakhs for past preceding three years are

eligible to participate

b) in the tender.

1. Agents are not eligible to participate in the tender

2. The tenderer shall not be supplier of medicines to Health

Department Govt. of Haryana/any Govt .

c) Only Analytical Laboratories having valid NABL accreditation and valid

ISO 17025:2005 certifications are eligible.

d) Only Analaytical Laboratories having valid Certificate of Good Laboratory

Practice (GLP) issued by the Licensing Authority are eligible.

End of section III

Page 49: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 49 of 95

SECTION IV: INSTRUCTION TO BIDDERS

Page 50: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 50 of 95

SECTION IV: INSTRUCTIONS TO BIDDERS

A INTRODUCTION

A. 4.1 Haryana Medical Services Limited Corporation (HMSCL) undertakes testing of

all the Drugs and Consumables being supplied by various vendors. For this

purpose testing laboratories (Govt. and Private) of appropriate standard would be

selected through open e-tender. The samples would be sent to the successful bidder

and they would be required to conduct the tests as per the pharmacopoeial

specifications. The Managing Director HMSCL, Bays No. 59-62, Sector 2,

Panchkula, Haryana hereby invites tender for the Empanelment of Analytical

Testing Laboratories for the Analysis of Drugs, Surgicals and Suture Items.

1. . Cover- A (TECHNICAL BID):-

Cover A should contain the following documents and annexures.

(a) The Earnest Money Deposit (EMD) shall be Rs. 10,000/-. The Earnest Money Deposit

shall be paid in the form of Demand Draft in the favour of Managing Director,

Haryana Medical Services Corporation Limited, Panchkula , payable at Panchkula.

The EMD should be sent with the tender form in Cover-A. EMD in the form of

Cheque/Cash/Postal Order will not be accepted. The EMD will not earn interest.

(b) The tenderer shall submit a checklist of the list of documents enclosed and their

page numbers. (In the enclosed Performa at Annexure–I).

(c) Attested Photocopy of approval on Form 37 valid up to date, issued by the State

Licensing Authority (Annexure – II).

(d) Non Conviction Certificate for the last three years, issued by the competent

authority submitted along with tender as Annexure III.

(e) Self Attested Photocopy of sale tax/service tax return whichever is applicable for the

last three year, submitted along with the tender (Annexure IV)

(f) Self attested copy of Income Tax Return for the last two Financial Years i.e2014-15 &

2015-16 (Assessment Year 2015-16 & 2016-17) with copies of Balance Sheet and Profit

and Loss Account duly certified by the CA / Auditors for the last three financial

years i.e., 2013-14, 2014-15 & 2015-16 submitted as Annexure V a, V b.

Page 51: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 51 of 95

(g) Documents to show that the Laboratory is accrediated by NABL, and certified by ISO

17025:2005 and is having Schedule L1 certificate from State Licensing Authority for

analysis attached as Annexure VI.

(h) Documentary evidence of having analysed Drugs /Surgical / Sutures for the 3

financial years 2013-14, 2014-15 & 2015-16 with a statement in the performa given in

Annexure VII indicating the numbers of tests done in each category.

(i) The following information in the formats given in Annexure VIII a to VIII c.

a) The list of qualified analysts approved from Drug Controller employed in the

laboratory showing the qualifications and experience of each with work assigned

and number of other employees.

b) The list of sophisticated instruments like HPLC, GC, FTIR, UV-VIS, Atomic

Absorption Spectrophotometer etc. available in the laboratory with detail of

specified instruments and list of reference standards.

c) Micro Biological facilities available in the laboratory and list of stock cultures.

(j) A declaration in the performa given in Annexure IX duly signed and notarized on a

Stamp paper of Rs. 100/-.

(k) Details of Laboratory in Annexure X.

(l) The tenderer should sign the bottom of all pages of the tender document with official

seal and enclose it in cover “A”.

(m) The labs will require to intimate the total capacity of testing the samples per

month and how much they will be able to test for Haryana Medical Service

Corporation Limited, Haryana (Annexure XI).

(n) List of Clientele of the laboratory for whom they did analysis in the previous year

duly certified by Charted Accountant in (Annexure XII).

4. 2 (Financial Bid):-

(a) The rates of testing charges of drug items filled in the BOQ/Financial Bid through

online process by bidders, as the rates and discount quoted should be exclusive of

taxes and other statuary charges. All other taxes and statuary charges should be

mentioned separately.

This tender is a e-tender and only on-line bid submission is possible. The e-tender

portal is designed by National Informatics Centre (NIC). The two bid system,

which is followed, has been designed to eliminate those bidders which do not

match the technical specifications, or not having the proven technology and to

eliminate firms that do not have the financial or technical capability to test the

Drug items.

Page 52: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 52 of 95

4.3 Cost of Bidding

(a) Bid fee: The bid fee along with the processing charges amounting to Rs 2500/- shall be

deposited in the form of DD/Banker cheque in favour of Managing Director, HMSCL,

payable at Panchkula. The bid fees shall be deposited in the office of HMSCL before the last

date and time of bid submission. The bidder shall submit the scanned copy of DD/Banker’s

cheque along with the technical bid online. The bid fees should be submitted separately for

each bid and the bids should be submitted for items listed in the Schedule of Requirement.

The bid fee is nonrefundable.

(b) The Bidder shall bear all costs associated with the preparation and submission of its bid

and HMSCL will not be liable for the cost incurred, regardless of the outcome of the bidding

process.

Page 53: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 53 of 95

SECTION V: THE BIDDING PROCEDURE

Page 54: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 54 of 95

A: THE BIDDING PROCEDURE

5.1 Bidding Procedure:

Pre-Contract :The online bidding process comprises of downloading the tender

document, prebid meeting if applicable, bid submission comprising of online and physical

(hard copy) submission of technical bid and only online submission of financial bid,

opening of technical bid and short-listing of technically responsive bids , opening of

financial bids, Notification of Award and signing of contract.

Post- Contract: Ordering, quality testing, payment & contract management as per terms &

conditions of Rate Contract.

5.2 Bid confidentiality and Clarification of Bidding Documents:

Bid confidentiality: It is expected from all the bidders that they will ensure that the

document to be used in the bid set will be given to reliable

person, and that a fully reliable person shall be authorized for digital signatures so that the

confidentiality of the bids/ rates is maintained up to bid opening & that no documents are

put to any misuse.

A prospective Bidder requiring any clarification of the Bidding Documents may notify the

HMSCL in writing at the HMSCL’s email indicated in the NIT. The HMSCL will respond in

writing to any request for clarification of the Bidding Documents which it receives between

date of publication and 7 days prior to the deadline for submission of bid. Written copies of

the HMSCL’s response (including an explanation of the query but without identifying the

source of inquiry) will be sent to all prospective Bidders trough email at the address quoted

by them or put on website.

B: PRE-BID AMENDMENTS OF BIDDING DOCUMENT

5.3 Pre-Bid Meeting:

5.3.1 The bidder or his official representative is invited to attend a pre-bid meeting which

will take place at Haryana Medical Services Corporation at conference Hall on 04.04.2016 at

11:30 AM

5.3.2 The purpose of the meeting will be to clarify issues and to answer questions on any

Page 55: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 55 of 95

matter related to the tender.

5.3.4 The Bidder is requested to submit any questions which he intends to raise in writing by

post or by email at least two working days in advance before the meeting.

5.3.5 Minutes of the meeting, including the text of the questions raised (without

identifying the source of enquiry) and the responses given will be published on official

website/s.

5.3.5 Non-attendance at the pre-bid meeting will not be a cause for disqualification of a

bidder. However it shall be presumed that there is no clarification needed at the end of such

bidder. However amendments if any carried out shall be applicable to all the bidders

irrespective of his not going through clarifications on the website.

5.4 Amendment of Bidding Documents

a) At any time prior to the deadline for submission of bids, the tester may, for any reason,

whether at its own initiative or in response to a clarification requested by a prospective

bidder, modify the Bidding Documents by an amendment.

b) All prospective bidders will be informed of the amendments by publishing on the e-

tendering portal.

c) In order to allow prospective bidders reasonable time to make amendments in preparing

their bid, the HMSCL may, at its discretion, extend the deadline for the submission of

bids.

C. PREPARATION OF BIDS

5.5 Language of Bid

The Bid prepared by the bidder and all correspondence and documents relating to the

bid exchanged by the Bidder and the HMSCL, shall be written in the English language.

Supporting documents and printed literature furnished by the Bidder may be written in

another language provided they are accompanied by an accurate translation of the

relevant passages in the English language in which case, for purposes of interpretation

of the Bid, the English translation shall govern.

5.6 Documents Comprising the Bid

Page 56: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 56 of 95

The bids can be downloaded www.etenders.hry.nic.in .

Contents of Bidding Documents include:

Section 1- Notice Inviting Tender (NIT);

Section 2- Schedule of Requirements;

Section 3- Eligibility criteria

Section4 - Instructions to the bidders

Section 5- Bidding Procedure

Section 6 - Contract Form

Section 7- Conditions of Contract ;

Section 8 - Form, Formats and Schedules

The detailed technical specifications and terms and conditions governing the quality

testing, payment are contained in the Tender Document. The online documents shall be

submitted through the e-tender portal www.etenders.hry.nic.in. Bidders have to enroll

themselves in the e-tender portal and digital signature certificate is required. Bidders

should have a Class II or above Digital Signature Certificate (DSC) to be procured

from any Registration Authorities (RA) under the Certifying Agency of India. Once,

the DSC is obtained, bidders have to register on www.etenders.hry.nic.in website for

participating in this tender. Website registration is a one-time process without any

registration fees. However, bidders have to procure DSC at their own cost. Bidders may

contact e-Procurement support desk of HMSCL through email: [email protected] for

assistance in this regard. The Technical Bid should be uploaded as scanned documents into

the NIC portal and a hard copy submitted separately. The blank price bid should be

downloaded as an Excel sheet, filled and uploaded. While preparing the Bid, the Bidder

should ensure that:

(a) All documents should be signed and sealed by the bidder on each page. The Photocopies

should be self-attested and stamped by the bidder and on each page.

(b) Documentary evidence establishing that the Bidder is eligible to bid and is qualified to

perform the contract if its bid is accepted;

Page 57: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 57 of 95

(c) Documentary evidence establishing that the goods and ancillary services to be supplied

by the Bidder shall conform to the Bidding Documents; and

(d) Bid Security furnished in accordance with Clause 5.14.

5.7 Bid Offer

i) All the quotes shall be in Indian Rupees only.

ii) Price Bid has to be submitted online only. No price bid should be submitted manually

otherwise bid shall be liable to rejection.

iii) There should not be any alteration or condition in the tender. If the same is found then

tender is liable to be cancelled.

5.8 BID PRICE

a) Bid Prices would comprise of the following:

Basic Price: The price of the testing of Drug items /Suture/Consumables Basic price

shall also include loading unloading& stacking, all other taxes, duties & levies and

incidental services if applicable.

Sales Tax/VAT: Applicable Sales Tax/VAT shall be quoted in this column in numeric

values and in Rupees (If the field is left blank, value will be taken as zero).

b) The details of the testing of Medicines and Medical Consumables are shown in schedule

of requirements.

c) The rates quoted and accepted will be binding on the bidder for full contract period as per

the validity of contract from the date of signing of agreement and any request for increase in

price will not be entertained till the completion of this tender period. Accordingly this clause

will be applicable for all testing orders placed during the contract period.

d) No bidder shall be allowed at any time on any ground, whatsoever it may be, to claim

revision or modification in the rates quoted by him. Representation to make correction in the

tender documents on the ground of Clerical error, typographical error, etc., committed by

the bidders in the Bids shall not be entertained after submission of the tenders.

e) The Pharmacopeial specification mentioned in schedule of requirement are only

indicative.

Page 58: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 58 of 95

5.9. Bid Security

a) The Bidder shall furnish, as part of its bid, bid security for the amount Rs. 10,000 for all

items. No exemption from payment of bid security is permitted

b) The bid security is required to protect the HMSCL against risk of Bidders conduct

which would warrant the security’s forfeiture.

c) The bid security shall be in Indian Rupees and shall be in one of the following forms:

A demand draft/ Bankers Cheque obtained from any scheduled bank in favour of

Managing Director, Haryana Medical Medical Services Corporation Limited, payable at

Panchkula. EMD/Bid security shall be deposited in the o/o HMSCL before the last date and

time of bid submission. The bidder shall submit the scanned copy of DD/Banker’s cheque

along with the technical bid online.

d) Any bid not secured in accordance with Clauses 5.9 (a) and (c) above will be rejected by

the HMSCL as non-responsive

e) Unsuccessful bidders bid security will be discharged/returned as promptly as

possible but not later than 30 days after the expiration of the period of bid validity

prescribed by the HMSCL. Bid security shall not carry any interest and shall be refunded

without any interest.

f) The successful bidder's bid security will be discharged upon the bidders signing the

contract, and furnishing the performance security.

g) The bid security may be forfeited:

(i) if a bidder withdraws its bid during the period of bid validity specified by the

Bidder on the Bid form; or

(ii) in case of a successful bidder, if the bidder fails:

to sign the contract in accordance with schedule specified in the Contract

to furnish performance security

5.10. Period of Validity of Bids

a) Bids shall remain valid for 180 days after the date of bid opening prescribed by the

Page 59: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 59 of 95

HMSCL. A bid valid for a shorter period may be rejected by the HMSCL as non-responsive.

b) In exceptional circumstances, the HMSCL may solicit the bidders consent for an

extension of the period of bid validity. The request and the responses thereto shall be made

in writing by e-mail. The bid security provided shall be suitably extended as mutually

agreed. A bidder may refuse the request without forfeiting its bid security. A bidder

granting the request for extension is not permitted to modify its bid.

5.11. Signing of Bid

The bid shall be signed by the Bidder or a person or persons duly authorized to bind

the Bidder to the Contract. The letter of authorization shall be indicated by written power-

of-attorney accompanying the bid. All pages of the bid, except for unnamed printed

literature, shall be initialed by the person or persons signing the bid.

D. SUBMISSION OF BIDS

5.12. Sealing and Marking of Bids

a) The bidder shall seal the “Technical bid”and submit the documents as part of

Technical Bid with following caption on the envelop along with online submission of

the same.

TECHNICAL BID: ONLINE TENDER DOCUMENT FOR EMPANELMENT OF

ANALYTICAL TESTING LABORATORIES FOR THE ANALYSIS OF ALLOPATHIC

& AYUSH DRUGS, SURGICAL AND SUTURE ITEMS

b) The inner envelopes and outer envelopes and the cover shall be addressed to the

HMSCL at the following address:

Haryana Medical Services Corp. Ltd.,

59-62, Sector 2, Panchkula, Haryana 134112

bear the NIT number and the word “Do not open before 05:00 PM on 11.04.2016.”

c) The inner envelopes shall indicate the name and address of the bidder to enable the

bid to be returned unopened in case it is declared “late”.

d) If the cover containing the outer envelope is not sealed and marked the HMSCL will

Page 60: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 60 of 95

assume no responsibility for the bid’s misplacement or premature opening.

5.13. Deadline for Submission of Bids

a) Bids must be received by the HMSCL at the address specified not later than

the time and date specified in the NIT. In the event of the specified date for the

submission of bids being declared a holiday, the bids will be received up to the

appointed time on the next working day.

b) The HMSCL may, at its discretion, extend this deadline for submission of bids

by amending the bid documents, in which case all rights and obligations of the

HMSCLs and bidders previously subject to the deadline will thereafter be subject

to the deadline as extended.

5.14. Late Bids

Any bid received by the HMSCL after the deadline for submission of bids prescribed

by the HMSCL, will be rejected and/or returned unopened to the Bidder.

5.15. Modification and Withdrawal of Bids

a) The bidder may modify or withdraw its bid after the bids submission, provided that

written notice of the modification or withdrawal is received by the HMSCL prior to the

deadline prescribed for submission of bids.

b) The bidders modification or withdrawal notice shall be prepared, sealed, marked and

dispatched .A withdrawal notice may also be sent by email but followed by a signed

confirmation copy, to reach HMSCL office not later than the deadline for submission of bids.

c) No bid may be modified or allowed to be withdrawn subsequent to the deadline for

submission of bids and withdrawal of the bid subsequent to deadline of submission of bids

shall result in the bidders forfeiture of its bid security.

E. BID OPENING AND EVALUATION

5.16. Opening of Bids by HMSCL

a) The HMSCL will open only the Technical bids of all bidders, in the presence of bidder's

representatives who chose to attend, at 12.00 PM on 12.04.2016 at the location specified in

the NIT or changed location as notified.

Page 61: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 61 of 95

The bidder’s representatives who are present shall sign a register evidencing their

attendance. In the event, the specified date of bid opening is declared a holiday, the bids

shall be opened at the appointed time and location on the next working day.

b) The bidder’s names, modifications, bid withdrawals and the presence or absence of the

requisite bid security and such other details as the HMSCL, at its discretion, may consider

appropriate will be announced at the opening. No bid shall be rejected at bid opening,

except the late bids, which shall be returned unopened to the bidder or the bids without

security.

c) The HMSCL will prepare minutes of the bid opening.

d) The “Financial Bid” will be opened after evaluation of “Technical bids” and the date and

time of opening of financial bid will be intimated to bidders whose bids are responsive and

who are selected by the HMSCL. Opening of Financial bid will be intimated only online.

5.17. Clarification of Bids

During evaluation of bids, the HMSCL may, at its discretion, ask the bidder for clarification

of the bid. The request for clarification and the response shall be in writing and shall be

submitted then and there by authorized person.

5.18. Bid Evaluation:

Bids will be evaluated by Bid Evaluation Committee constituted by the HMSCL. The

decisions of the Bid Evaluation Committee on whether the tenders are responsive or

non-responsive or requiring clarifications will be published. The Bid Evaluation would

comprise of the following steps:

a) Eligibility Evaluation

b) Technical Evaluation

c) Financial Evaluation

a) Eligibility Evaluation: The Bid will be evaluated for Eligibility Criteria set out in

Section III of this DNIT

Page 62: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 62 of 95

b) Technical Evaluation: For evaluation The Bid evaluation committee would

scrutinize documents submitted by the Bidder, seek clarifications wherever required,

undertake demonstration, conduct test from labs, technically evaluate the item on the

specifications in the DNIT. The HMSCL reserves the right to carry out inspection of

bidder’s premises for assessing the capacity/capability/eligibility of the firm to make

supplies and to ensure that good Laboratory practices are being followed by

Laboratories..

The bidder will be informed of the deficiencies in the bids if any and will be given

time by the HMSCL to clarify the deficiencies.

c) Financial Evaluation

i) Financial bids submitted online will be opened of all the technically qualified bidders. The

total of all costs be will be taken for evaluation and bid ranking.

ii) For the purpose of financial evaluation of bids all technically qualified bid will opened

and L1 will be identified. As testing of Drug is a confidential matter so there is need to have

more than one empanelled lab for each drug so all technically approved bidders will be

called and asked for matching the L1 rates.

5.19. Contacting the HMSCL

a) Subject to Clause 5.22 no bidder shall contact the HMSCL on any matter relating to its

bid, from the time of bid opening to the time the contract is awarded.

b) Any effort by a bidder to influence the HMSCL in the HMSCL bid evaluation, bid

comparison or contract award decisions may result in rejection of the bidders bid.

c) The bidders shall not make attempts to establish unsolicited and unauthorized contact

with the Tender Inviting Authority or Tender Scrutiny Committee or Tender accepting

authority, after opening of the bids and prior to the notification of award and any attempt

by any bidder to bring to bear any extraneous pressures on any Authority bidder shall be

sufficient reason to disqualify the bidder.

d) Notwithstanding anything contained in clause 5.20, the Tender Inviting Authority or the

Page 63: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 63 of 95

Tender Accepting Authority, may seek bona fide clarifications from bidders relating to the

bids submitted by them during the evaluation of bids, and the bidder will reply back within

seven calendar days with the documentary proof.

F. AWARD OF CONTRACT

5.20 Post Qualification

a) In the absence of pre-qualification, the HMSCL will determine to its satisfaction

whether the bidder that is selected as having submitted the lowest evaluated responsive bid,

meets the criteria specified in Clause 5.18 and is qualified to perform the contract

satisfactorily.

b) The determination will take into account the bidders financial, technical and testing

capabilities. It will be based upon an examination of the documentary evidence of the

bidders qualifications submitted by the bidder, pursuant to Clause 5.12, visit to Bidder’s

premises as well as such other information as the HMSCL deems necessary and appropriate.

c) An affirmative determination will be a pre-requisite for award of the contract to the

bidder. A negative determination will result in rejection of the bidders bid, in which event

the HMSCL will proceed to the next lowest evaluated bid to make a similar determination of

that bidders capabilities to perform satisfactorily.

5.21 Award Criteria

Subject to Clause 5.18, the HMSCL will award the contract to the successful bidder whose

bid has been determined to be substantially responsive and has been determined as

the lowest evaluated bid, provided further that the bidder is determined to be qualified to

perform the contract satisfactorily.

5.22. HMSCL right to vary quantities at time of award

a) The HMSCL reserves the right at the time of award of contract to increase or decrease

the quantity of goods and services originally specified in the schedule of requirements

without any change in unit price or other terms and conditions.

b) HMSCL reserves the right to accept any bid and to reject any or all bids or cancel the bid.

The HMSCL reserves the right to accept or reject any bid, and to annul the bidding process

Page 64: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 64 of 95

and reject all bids at any time prior to award of contract, without thereby incurring any

liability to the affected bidder or bidders or any obligation to inform the affected bidder or

bidders of the grounds for the HMSCL’s action.

5.23. Notification of Award and Letter of Offer

Prior to the expiration of the period of bid validity, the HMSCL will notify the successful

bidder in writing by registered letter or by email or fax. This would be treated as a Letter of

Offer. At the same time, the HMSCL will send the bidder the contract form provided in the

bidding documents for signature.

5.24. Acceptance of Award

Soon after the notification of award the successful Bidder shall submit the letter of

acceptance / confirmation to the HMSCL for the execution of contract along with

Performance Security. The bidder will submit the performance security and signed contract

form within 7days. HMSCL reserves the right to extend this period by another seven days.

After 7 days or the extended period the notice of award shall be withdrawn and Bid Security

shall stand forfeited.

5.25. Performance Security

a) Within 7 days of the receipt of notification of award from the HMSCL or extended period,

the successful bidder shall furnish the performance security in prescribed/specified form

in accordance with the conditions of contract.

5.27. Signing of Contract

a) Within 7 days of receipt of notification of award or extended period the successful bidder

shall sign the contract agreement.

b) Failure of the successful bidder to comply with the requirement shall constitute sufficient

grounds for the annulment of the award and forfeiture of the bid security, in which event

the HMSCL may make the award to the next lowest evaluated bidder or call for new bids.

End of section V

Page 65: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 65 of 95

SECTION VI: CONTRACT FORM

Page 66: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 66 of 95

CONTRACT DOCUMENT

AGREEMENT

This agreement is made and is being entered into on this ________day of ________

2015, between the Haryana Medical Services Corporation Limited (HMSCL) acting through

Managing Director, Haryana Medical Services Corporation Limited (HMSCL), Haryana

having its office at Sector 2, Panchkula (hereinafter referred to “HMSCL”) which term or

expression unless excluded by or repugnant to the subject or context shall mean and include

its successors in office and assigns of the First Part,

AND

__________________________________, a company registered under the Companies Act,

1956 (Act 1 of 1956) registered firm, having its registered office at _______________ acting

through Chief Executive Officer (CEO) duly authorized to enter into agreement (hereinafter

referred to as “Service Provider”) of the Second Part (‘HMSCL’ and ‘Service Provider’ shall

individually be referred to as “Party” hereto and collectively as “Parties”).

Whereas,-

(a) The Service Provider has agreed to test the Drugs, Consumables, Surgical and

suture items for the HMSCL with specifications mentioned in the Schedule A,

attached hereto and mentioned at the prices noted there against; and

(b) The Service Provider has deposited with the HMSCL a performance

guarantee for a sum Rs. 30,000/- in the shape of fixed deposit for due and

faithful performance of this agreement failing which Performance Guarantee

shall be liable to be encashed by HMSCL.

Now, therefore, for the mutual promises and consideration set out herein, the

Parties have agreed to the following terms and conditions, namely:-

1.1 DEFINITIONS

For the purposes of this Agreement unless the subject or context otherwise requires, the

following terms expressed shall mean as under,-

Page 67: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 67 of 95

1.1.1 “Agreement” shall mean and include the terms and conditions including amendments,

contained in the invitation to tender floated for the empanelment of Analytical Testing

laboratories for the test and analysis of Drugs, Consumables, Surgical and suture items

for HMSCL for the period of agreement, the instruction to tenderers, the conditions of

tender and acceptance of tender, particulars hereinafter defined and those general and

special conditions that may be added from time to time. It shall also mean this

agreement together with its Schedules, Appendices and Annexures. The following

Schedule, shall also be a part of the agreement:

1. Schedule A : List of item, specifications with approved testing charges

(inclusive of all taxes).

1.1.2 “Agreement period” shall mean a period of two years from the Effective Date as

specified in this agreement.

1.1.3 “Applicable law” shall mean the laws and any other instruments having the force of

law in India as they may be issued and in force from time to time.

1.1.4 “Lab” shall mean the Provider of Services to HMSCL, as defined under the agreement.

1.1.5 “Effective Date” shall mean the date of signing of this agreement by both the parties.

1.1.6 “Government” shall mean the Government of Haryana.

1.1.7 “HMSCL” shall mean Haryana Medical Services Corporation Limited including its

successor in office and its assigns.

1.1.8 Other terms used in this agreement but not defined shall have the same meaning as

assigned to such terms under the Drugs and Cosmetics Act, 1940 and rules framed

there under, as the case may be, as amended from time to time.

1.2 TERM AND TERMINATION

1.2.1 Unless otherwise terminated earlier, the term of this agreement shall be valid for a

period of two years starting from Effective Date.

1.2.2 Parties to this agreement may mutually agree in writing to extend the term and/or

scope of this agreement or modification to other terms governing this agreement.

1.2.3 This agreement can be terminated by the HMSCL in case:-

Page 68: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 68 of 95

(a) The Service Provider fails or neglects or refuses to faithfully perform any of the

covenants on his part herein contained. On termination, it shall be lawful for the

HMSCL to terminate and encash the performance guarantee furnished by the

Service Provider vide this agreement.

(b) The Service Provider fails, neglects, or refuses to observe, perform, fulfill and keep,

all or any one or more or any part of any one of the Covenants, stipulation and

provisions herein contained.

it shall be lawful for the HMSCL on any such failure, neglect or refusal, to put an

end to this Agreement and thereupon every article, cause and thing herein

contained on the part of the HMSCL shall cease and be void, and in case of any

damage, loss, expenses, difference in cost or other moneys / performance guarantee

from out of any moneys for the time being payable to the Service Provider under

this and/or any other Contract. In case such last mentioned moneys are insufficient

to cover all such damages, losses, expenses, difference in cost and other moneys as

aforesaid, it shall be lawful for the HMSCL to appropriate the Performance

Guarantee made by the Service Provider as herein before mentioned to reimburse /

compensate all such damages, losses, expenses, difference in cost and other money,

as the HMSCL shall have sustained, incurred or been put to by reason of the Service

Provider having been guilty of any such failure, negligence or refusal as aforesaid or

other breach in the performance of this agreement.

(c) If at any time during the course of the agreement, it is found that any information

furnished by the Service Provider to the HMSCL, either in his Tender or otherwise,

is false, the HMSCL may put an end to the Contract/Agreement wholly or in part

and thereupon the Performance Guarantee made by the Service Provider shall be

forfeited and encashed.

1.2.4 The HMSCL reserves the right to terminate the agreement in whole or in part and after

giving a 30 days notice in writing to the Service Provider. The Service Provider will not

be entitled for any compensation whatsoever in respect of such termination of the

Contract/Agreement by the HMSCL.

The termination of this agreement in whole or in part under these conditions shall not

Page 69: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 69 of 95

be affected by the acceptance, meanwhile or subsequently of reports accepted or made

at any station whether in ignorance of the termination or otherwise

1.3 FRAUDULENT PRACTICES, BRIBERY AND CORRUPTION

The Service Provider represents and undertakes that it has not given, offered or

promised to give, directly or indirectly any amount, gift, consideration, reward,

commission, fees, brokerage or inducement to any person in service of the Government

in procuring the Contract or forbearing to do or for having done or forborne to do any

act in relation to the obtaining or execution of the Contract or obtaining a contract or

showing or forbearing to show favour or disfavour to any person in relation to the

Contract. Any breach of the aforesaid undertaking by the Service Provider or any one

employed by it or acting on its behalf or for its benefit (whether with or without its

knowledge) or the commission of any offence by the Service Provider or anyone

employed by it or acting on its behalf, as defined in the Prevention of Corruption Act,

1988 (Act 49 of 1988) or any other Act enacted for the prevention of corruption shall,

without prejudice to any other legal action, entitle the HMSCL to cancel the agreement

either wholly or in part and forfeit and encash the performance guarantee.

The Service Provider shall not be in any way interested in or concerned directly or

indirectly with, any of the Officers, Subordinate or Servants of the HMSCL in any

trade, business or transactions nor shall the Service Provider give or pay or promise to

give or pay any such officer, subordinate or servant directly or indirectly any money or

fee or other consideration under designation of “Custom” or otherwise; nor shall the

Service Provider permit any person or persons whomsoever to interfere in the

management or performance hereof under power of attorney or otherwise without the

consent in writing of the HMSCL obtained in first hand. If at any time during the

course of the Contract the same is found, the agreement shall be terminated and the

Service Provider blacklisted without giving any notice in writing and performance

guarantee shall be forfeited and encashed.

1.4 INSPECTION OF LABORATORIES

In respect of analysis of items in Schedule A, the Service Provider shall allow

inspection of the laboratory and verification of the relevant documents at any time

during the continuance of the tender period by team of experts / officials whom the

HMSCL may depute for the purpose. The Service Provider shall extend all facilities to

the team to enable them to inspect sample, storage, reagents, instruments, all relevant

Page 70: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 70 of 95

records, analysis etc. in the lab. The Managing Director, HMSCL or his authorized

representatives may also inspect any laboratory empanelled, at any point of time

during the continuance of the contract/agreement and terminate its empanelment and

blacklist the laboratory based on violations brought out during such inspections.

1.4.1 Non-assignment- The Service Provider shall test the drugs, consumables, surgicals and

suture items in its lab and shall not assign any sample for testing to any other lab.

1.5 PENALTIES

1.5.1 On empanelment and entrustment of the job.-

(a) The Service Provider shall acknowledge the receipt of sample by online

Within 24 hours of the receipt of the same.

(b) The Service Provider shall furnish the test reports within the time specified below:

I. 8 days of receipt of the sample in case of items not requiring sterility test.

II. 21 days of receipt of the sample in the case of items requiring sterility test.

III. Within 24 hrs. of the receipt of the sample, the information in appropriate

format should be uploaded on designated website or web portal.

Provided that the Managing Director, HMSCL may on sufficient cause being

shown or under exceptional circumstances beyond the control of Service

Provider, condone the delay upto two days in case of acknowledgement of

samples and two weeks in case of report.

1.5.2 I. For delay upto 10 days, after the stipulated time, 5% of the testing charges per

day would be deducted as penalty upto 100% of the maximum of testing charges

of that particular test.

II. If the delay upto 10 days occur consecutively for four times, or more than 8 times

in a year, then the penalty for subsequent delays would be 10% of testing charges

per day upto 100% of the maximum of testing charges of that particular test.

III.

IV.

If the delay is more than 10 days after the stipulated time, 10% of the testing

charges per day would be deducted as penalty upto 100% of the maximum of

testing charges of that particular test for subsequent delays.

If there are five consecutive instances of any delay in the reporting of the results

by the empanelled laboratories, the agreement clause may be annulled.

1.5.3 To assess the correctness of the test results being given by the Service Provider, random

samples could also be sent simultaneously to the Government Analyst or atleast to two

Page 71: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 71 of 95

other empanelled laboratories for testing and if any variation is found, the result would

be informed to the Service Providers. If there is any variation in the analytical reports

furnished by the Service Providers and the report of the Government Lab or other

empanelled lab for 3 times in assay test and 4 times for other than assay, in a year, the

agreement shall stand terminated and Service Provider blacklisted for a period of five

years after following the due process. On termination, the performance guarantee shall

stand forfeited and encashed.

a. All the tests mentioned in IP/BP/USP/Drugs & Cosmetics Act. , BIS Etc., (as the

case may be) should be carried out for each and every sample. The results obtained

in the test should be mentioned in figures (wherever possible).

b. In all reports where there is some value assigned to result then the report should

mention the actual value and permissible limits.

c. COMPLIES” or “PASSES” in the result column of the report will be treated as

incomplete report, if the result has some value.

d. Every test report must have remarks i.e. of Standard Quality or Not of Standard

Quality.

e. Reports should be sent on Form-39 as specified in Drugs and Cosmetics Rules

1945.

f. Reports should have Sr.No., Description of tests, Specifications & Results.

g. Reports should be attached along with Spectra / Chromatography data sheets if

applicable or any other relevant graphs required.

h. Report should be uploaded on the designated website and simultaneously sent to

designated E-mail.

i. All test reports should be submitted to the Managing Director, Haryana Medical

Services Corporation Limited in triplicate. In case of failure of a sample, the result

Page 72: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 72 of 95

should be communicated immediately to the Managing Director, Haryana

Medical Services Corporation Limited through phone / Fax / E-mail and the report

should be sent with protocol.

j. Against each test the Analytical Laboratory must mention the following details in a

separate sheet:

a. Name of the Reference Standard

b. Lot no. of Pharmacopoeial Reference Standard

c. Date and number of test certificate of reference standard in case of

Pharmacopoeial Reference Standard.

k. If in any circumstances (like break down of instrument, non availability of reference

standard etc.) the Analytical Laboratory is unable to undertake analysis for a

sample, the same should be reported within 24 hours of receipt of such a sample by

FAX or Email and the sample should be returned to the Managing Director,

Haryana Medical Services Corporation Limited.

l. If any sample is received in a damaged condition by the laboratory, the sample

should not be analysed and the information should be sent immediately to the

Managing Director, Haryana Medical Services Corporation Limited by FAX or E-

mail.

m. The Managing Director, Haryana Medical Services Corporation Limited or his

authorized representative(s) has / have the right to inspect the laboratories of the

tenderers who have submitted tenders, before taking any decision regarding

empanelment. Similarly, the Managing Director, Haryana Medical Services

Corporation Limited or his authorized representatives may also inspect any

laboratory empanelled, at any point of time during the continuance of the

tender and terminate / cancel its empanelment or any orders issued to the

laboratory or not to entrust any further testing job to the laboratory based on facts

brought out during such inspections.

n. No payment will be made for the incomplete analysis or incomplete report.

o. HMSCL will reject the tenders of blacklisted Laboratories.

Page 73: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 73 of 95

1.5.4 Non performance of any tender or empanelment conditions will disqualify the Service

Provider to participate in the tender process for the next five years.

1.5.5 If it is revealed that the Service Provider is involved in any form of fraud, corruption or

malpractices and collusion with the HMSCLs of Health Department of Haryana

Government, the Service Provider will be blacklisted for a period of five years and

performance guarantee forfeited/encashed. The Service Provider shall also be liable for

action under criminal law.

1.5.6 No payment shall be made for the incomplete analysis or incomplete report.

1.5.7 In the event of any dispute arising out of the contract/agreement such dispute would be

subject to the jurisdiction of the civil courts at Panchkula alone.

1.5.8 During the course of the agreement if it is found that the Service Provider/ Laboratory

has been blacklisted by any National Standardizing body/Government body of any

State for malpractices or its NABL accreditation or its certification regarding GLP is not

renewed, then the lab shall be blacklisted and contract shall be terminated after giving

notice of thirty days in writing and performance guarantee shall be forfeited/encashed.

1.6 RECOVERY OF MONEYS DUE TO THE HMSCL FROM THE LABORATORY

All expenses, damages and other moneys payable to the HMSCL by the Service

Provider under any provision of this agreement may be recovered from the amounts

due from the HMSCL and in case such amounts are insufficient to fully cover such

expenses, damages or other money payable, it shall be lawful for HMSCL to recover

the balance amount from the Performance Guarantee of the Service Provider and all

other money held by the HMSCL. In case where Performance Guarantee is insufficient,

then it shall also be lawful for the HMSCL to recover the balance of the said expenses,

damages and moneys, if necessary, by resorting to legal proceeding against the Service

Provider.

1.7 FEES AND PAYMENTS; SUBMISSION OF BILLS FOR UNDERTAKING

ANALYSIS

Page 74: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 74 of 95

No advance towards any analysis will be made to Service Provider. All payments will

be made against valid invoices/bills through banking channels after deduction of

income tax as per the provision of Income Tax Act, 1961,. The invoices/bills should be

raised on monthly basis by the Service Provider in view of test reports submitted by

him during the month.

1.8 BANKRUPTCY OF THE SERVICE PROVIDER

In case the Service Provider at any time during the continuance of the Contract

becomes bankrupt or insolvent or commits any act of bankruptcy or insolvency under

the provisions of any law in that behalf for the time being in force, it shall be lawful for

the HMSCL to put an end to the agreement, and thereupon every article, clause and

thing herein contained to be operative on the part of the HMSCL, shall cease and be

void and the HMSCL shall have all the rights and remedies given to him under the

preceding clauses.

2.0 SERVING OF NOTICE ON SERVICE PROVIDER

2.0.1 All notices or communication relating to or arising out of this agreement or any of the

terms thereof shall be considered duly served on or given to the Service Provider if

delivered to him, left or affixed at his premises, place of business or where the Service

Provider ordinarily resides.

2.0.2 It is hereby agreed and declared between the parties hereto that in case any question of

dispute arises touching the construction or wording of any of clause herein contained

on the rights, duties, liabilities of the parties hereto or any other way, touching or

arising out of the presents, the decision of the Managing Director, HMSCL in the

matter shall be final and binding.

2.1 DISPUTE RESOLUTION

Any dispute or difference, whatsoever, arising between the Parties to this agreement

arising out of or in relation to this agreement shall be resolved by the Parties through

mutual consultation, in good faith and using their best endeavors. To this end, the

Parties agree to provide frank, candid and timely disclosure of all relevant facts,

information and documents to facilitate discussions between them/ their

representatives or officers.

Page 75: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 75 of 95

2.2 ARBITRATION

If a dispute is not resolved amicably in accordance with clause 2.1 within 30 days or

such extended period as the Parties may mutually agree, the Parties or either of them

may refer the dispute to a sole Arbitrator to be appointed by the mutual consent of both

the Parties herein. If the Parties cannot agree on the appointment of the Arbitrator

within a period of one month from the notification by one Party to the other for

reference to arbitration of such dispute, then the Arbitrator shall be nominated as per

provisions of the Arbitration and Conciliation (Act 26 of 1996) and this Act will also be

applicable to the entire process of arbitration and the award made there under shall be

final and binding upon the parties hereto, subject to legal remedies available under the

law. The Arbitration proceedings will be held in English at Panchkula/Chandigarh or at

such other place as the Arbitrator may determine.

2.3 GOVERNING LAW AND JURISDICTION

This agreement and all questions of its interpretation shall be construed in accordance

with the Laws of India. The Courts at Panchkula alone shall have jurisdiction.

2.4 NO PARTNERSHIP

This agreement shall not be interpreted or construed to create an association, joint

venture or partnership between the Parties, or to impose any partnership obligation or

liability upon either Party, and neither Party shall have any right, power or authority to

enter into any agreement or undertaking for, or act on behalf of, or to act as or be an

agent or representative of, or to otherwise bind, the other Party save as expressly

provided herein.

2.5 The Service Provider acknowledges that it has made itself fully acquainted with all the

conditions and circumstances under which the services are required or will have to be

made or furnished under the agreement and with all the terms, clauses conditions,

specifications and other details of the contract and the Service Provider shall not plead

ignorance of any of those as excuses in case of complaint against or on rejection of

services tendered by him or with a view either to asking for enhancement of any rates

agreed to in the contract or to evade any of his obligations under the contract.

Page 76: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 76 of 95

For and on behalf of Service Provider For and on behalf of HMSCL

Signature

Name

Designation

Address

Date :

Place:

Signature

Name

Designation

Address

Date :

Place:

End of section VI

Page 77: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 77 of 95

SECTION VII: CONDITIONS FOR CONTRACT

Page 78: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 78 of 95

SECTION VII: CONDITIONS OF CONTRACT

7.1 Application : The Conditions of Contract shall be deemed to form and be read

and construed as part of the agreement at of Section VI.

7.2 Definitions: In this contract the following terms shall be interpreted as

indicated:

(a) “The Contract” means this agreement entered into between the HMSCL and the

Testing Laboratories as recorded in the Contract Form signed by the parties,

including NIT all the attachments and appendices thereto and all documents

incorporated by reference therein;

(b) “The Contract Price” means the price payable to the under Testing Laboratories

the Contract for the full and proper performance of its contractual obligations;

(c) “CC” means the Conditions of Contract contained in this section.

(d) “The HMSCL” means the Organisation send by the test request the Goods, i.e

Haryana Medical Services Corporation Ltd.

(e) “The laboratories” means the individual or firm who is eligible under NIT for

Testing the Goods under this Contract;

(f) Rate Contract: Rate Contract is a contract for the supply of stores at

specified rates during the period covered by the contract.

7.3.1 Within 7 days from the date of issue of Notification of Award, the HMSCL shall furnish

performance security to the empanelled Laboratories for an amount of 10% of the

contract value valid upto 180 days after the date of completion of performance

obligations including the warranty obligations. The contract value means the total

value of the items as specified in Schedule for which the HMSCL may place order

during the contract period.

Page 79: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 79 of 95

7.3.2 The Performance Security shall be denominated in India Rupees and shall be in

the form of a Bank guarantee issued by a nationalized/ scheduled bank located

in India and in the form provided in the bidding Documents or any other form

acceptable to the HMSCL.

7.3.3 The proceeds of the performance security shall be payable to the HMSCL as

compensation for any loss resulting from the HMSCL’s failure to

complete its obligations under the Contract. If the loss suffered is more than the

performance security then the performance security then it shall be adjusted

against payments due & if it cannot be adjusted then it shall be recovered as per

law. If at any stage the performance security gets adjusted then the HMSCL shall

have to give fresh Performance Security to continue with this contract with in

seven days or the contract shall stand cancelled and purchases shall be made at

the risk and cost of HMSCL for the remaining contract period.

7.3.4 The performance security will be discharged by the HMSCL and returned to the

empanelled Lab not later than 180 days following the date of completion of

the HMSCL’s performance obligations. The Corporation shall not pay any

interest on Performance security. In the event of any contract amendment, the

HMSCL shall, within 15 days of receipt of such amendment, furnish the

amendment to the Performance Security, rendering the same valid for the

duration of the Contract, as amended for further extended period.

7.3.5 The firms which are registered as Small Scale Industry unit of Haryana, shall be

required to submit the PBG, as per Haryana Govt. Rules.

7.4 Termination of Contract:

7.5 Termination for Default

Page 80: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 80 of 95

(a) The HMSCL may, without prejudice to any other remedy for breach of contract, by

written notice of default sent to the laboratory, terminate the Contract in whole or part if

(i) the Laboratory fails to deliver any or all of the goods within the time period(s) specified

in the Contract, or within extended period granted by the HMSCL or

(ii) if the Laboratories fails to perform any other obligation(s) under the Contract; or

(iii) if the Laboratories, in the judgment of the HMSCL, has engaged in fraud and

corruption, as , in competing for or in executing the contract.

(b) In the event, the HMSCL terminates the Contract in whole or in part, the HMSCL may

testing upon such terms and in such manner as it deems appropriate, Goods or Services

similar to those testing, and the Laboratory shall be liable to the HMSCL for any additional

costs for such similar Goods. However, the Laboratory shall continue the performance of

the Contract to the extent not terminated.

7.6 Termination for Insolvency

(a) The HMSCL may at any time terminate the Contract by giving written notice to the

Laboratories, if the Laboratories become bankrupt or otherwise insolvent

7.7 Termination for Convenience

(a) The HMSCL, may by written notice sent to the Laboratories, may terminate the Contract,

in whole or in part, at any time for its convenience. The notice of termination shall specify

that termination is for the HMSCL’s convenience, the extent to which performance of work

under the Contract is terminated, and the date upon which such termination becomes

effective.

7.8. Force Majeure

Page 81: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 81 of 95

7.8.1 The Laboratory shall not be liable for forfeiture of its performance security,

liquidation damages or termination for default, if and to the extent that, its delay in

performance or other failure to perform its obligations under the Contract is the result of an

event of Force Majeure.

7.8.2 For purposes of this Clause “Force Majeure” means an event beyond the control of the

HMSCL and not involving the Laboratories fault or negligence and not foreseeable.

Such events may include, but are not limited to, acts of the HMSCL either in its

sovereign or contractual capacity, wars or revolutions, fires, floods, epidemics, quarantine

restrictions and freight embargoes.

7.8.3 The bidder shall be entitled to the benefit of this clause only if it informs in writing of

the circumstances amounting to Force Majeure to Haryana Medical Services Corporation

Limited (HMSCL) for each consignment/dispatch separately within 72 hours of the

happening thereof by fax/e-mail immediately, followed by a confirmatory letter sent by

Registered Post. Unless otherwise directed by the HMSCL in writing, the Laboratories shall

continue to perform its obligations under the Contract as far as is reasonably practical, and

shall seek all reasonable alternative means for performance not prevented by the force

majeure event.

7.9 Indemnity:

The Managing Director HMSCL, all employees of HMSCL shall remain at all times fully

indemnified and the HMSCL shall keep every concerned Department duly indemnified

against any chemical analysis or statutory inspections/check during the life of the

Equipment of the items supplied. It is made clear that no suit, prosecutions or any legal

proceedings shall lie against the Managing Director, HMSCL or any other officer/official of

the State Govt. / Corporation for anything that is done in good faith or intended to be done

in pursuance of the tender.

Page 82: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 82 of 95

7.10 Fraudulent and Corrupt practices

For bidders & HMSCLs:

HMSCL requires that the bidders, HMSCLs and contractors and their authorized

representatives/agents observe the highest standard of ethics during the procurement and

execution of such contracts. In pursuance of this policy, the HMSCL; defines, for the

purposes of this provision, the terms set forth below as follows:

(i) “Corrupt practice” is the offering, giving, receiving or soliciting, directly or

indirectly; of anything of value to influence improperly the actions of another

party (“another party” refers to a public official acting in relation to the procurement

process or contract execution]. In this context, “public official” includes staff and

employees of other organizations taking or reviewing procurement decisions.

(ii) “fraudulent practice” is any act or omission, including a

misrepresentation, that knowingly or recklessly misleads, or attempts to

mislead, a party to obtain a financial or other benefit or to avoid an obligation

(a “party” refers to a public official; the terms “benefit” and “obligation” relate to the

procurement process or contract execution; and the “act or omission” is intended to

influence the procurement process or contract execution).

(iii) “collusive practice” is an arrangement between two or more parties

designed to achieve an improper purpose, including to influence improperly

the actions of another party [“parties” refers to participants in the procurement

process (including public officials) attempting to establish bid prices at artificial, non

competitive level].

(iv) “Coercive practice” is impairing or harming, or threatening to impair or harm,

directly or indirectly, any party or the property of the party to influence

improperly the actions of a party (a “party” refers to a participant in the

procurement process or contract execution).

Page 83: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 83 of 95

(v) “Obstructive practice” is:

deliberately destroying, falsifying, altering or concealing of evidence material to

the investigation or making false statements to investigators in order to

materially impede a investigation into allegations of a corrupt, fraudulent,

coercive or collusive practice; and/or threatening, harassing or intimidating

any party to prevent it from disclosing its knowledge of matters relevant to the

investigation or from pursuing the investigation; or

acts intended to materially impede the exercise of the HMSCL’s inspection

and audit rights provided for under sub-clause (e) below

HMSCL may take following actions in case a bidder/ HMSCL is found guilty

of above or any other terms and conditions which are mutually agreed in

writing by both the parties.

i) will reject a proposal for award if it determines that the bidder

considered for award has, directly or through an agent, engaged in corrupt,

fraudulent, collusive, coercive or obstructive practices in competing for the

contract in question;

ii) will cancel the contract if the HMSCL determines at any time that the bidder,

HMSCL and contractors and their sub contractors engaged in corrupt,

fraudulent, collusive, or coercive practices.

iii) will sanction a firm or individual, including declaring ineligible, either

indefinitely or for a stated period of time, to be awarded a contract if it at any

time determines that the firm has, directly or through an agent, engaged in

corrupt, fraudulent, collusive, coercive or obstructive practices in

competing for, or in executing, a contract; and

iv) Will have the right to inspect the accounts and records of the bidders,

Page 84: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 84 of 95

HMSCL, and contractors and their subcontractors/authorized representatives

and to have them audited by auditors appointed by the HMSCL.

End of section VII

Page 85: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 85 of 95

SECTION VIII: FORM AND FORMATS

Page 86: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 86 of 95

Annexure-I

S.No. Annexure

No.

Documents Submitted(√)/

Not

Submitted(X)

Page No.

1 II Attested Photocopy of Analytical License

2 III Non Conviction Certificate

3 IV Attested Photocopy of Sales Tax/Service

Tax Return

4 V a, V b Self certified and stamped copy of(a)

Income Tax Return & (b)Balance Sheet

and Profit and Loss Account

5 VI (a) NABL Certification

(b) ISO 17025:2005 Certification (c)

Schedule L1 Certification

6 VII Documentary evidence of 3year analysis

of Drugs /Surgical / Sutures

7 VIII a to

VIII c

The list of(a) qualified personnel’s

(b)Instruments and Reference

Standards(c)Micro Biological facilities

8 IX Declaration Performa

9 X Details of Laboratory

10 XI Total capacity of analysis of the lab

11 XII List of clientele of the laboratory

12 XIII Rates of Analysis of Drugs, Surgical,

Sutures

Page 87: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 87 of 95

For Annexure II to VI, copies of documents to be attached.

For Annexure VII to XIII format has been given.

Annexure-II, III, IV, V a , V b & VI

No format given.

Copies of concerned documents to be attached as Annexures.

Page 88: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 88 of 95

ANNEXURE VII

Ref. Clause No: 4 (h)

PROFORMA FOR PERFORMANCE STATEMENT

(For a period of last 3 years)

Name of the Laboratory: ____________________________________

Address: ____________________________________

____________________________________

Types of Samples Analysed No. of Samples Analysed

2013-14, 2014-15& 2015-16

01. Tab. / Cap. / Pessaries

02. Injectable

03. Liquid Orals

04. Ointments / Creams / Gels

05. Others (Drugs)

06. Surgicals (Specify item names)

07. Sutures (Specify types)

Signature :

Date :

Name of the Lab :

Office Seal :

Page 89: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 89 of 95

ANNEXURE –VIII (a)

Ref. Clause No: 4 (i) (a)

PERSONNEL IN QC DEPARTMENT

Name of the

approved qualified

analyst from drug

controller

Designation Highest

Qualification

Experience (relevant to

analysis of

drugs/surgical/sutures

Staff other than specified above Number

Signature :

Date :

Name of the Lab :

Office Seal :

Page 90: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 90 of 95

ANNEXURE – VIII (b)

Ref. Clause No: 4(i) (b)

LIST OF SOPHISTICATED EQUIPMENT/ APPARATUS/REFERENCE STANDARDS

AVAILABLE IN THE LAB

(i) Name of the Equipment in Description Date of Installation

working Conditions with total No. (Name of Manufacturer)

1. HPLC

2. Gas Chromatograph

3. Atomic Absorption Spectrophotometer

4. IR Spectrophotometer

5. UV Spectrophotometer

6. Dissolution Test Apparatus

7. Polarimeter

8. Potentiometer Autotitrator

(ii) Name and number of the Other Description Date of installation

Equipments in working Conditions (Name of Manufacturer)

(iii) List of Reference Standards

Name Quantity

Signature :

Name of the Lab :

Page 91: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 91 of 95

Date :

ANNEXURE – VIII(C)

Ref. Clause No: 4(i) (c)

FACILITIES IN THE MICROBIOLOGICAL SECTION

I. LIST OF STOCK CULTURES AVAILABLE-

II. LIST OF EQUIPMENT / APPARATUS Date of installation Total number

(Ex. INCUBATORS ETC.)

Signature :

Name of the lab :

Date :

Page 92: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 92 of 95

ANNEXURE IX

Ref. Clause No: 4 (j)

DECLARATION FORM

I / We _______________________________(Name of the tenderer)

having our office at ______________________________________________

Lab at -----------------------------------------------------------------------------------------------do declare

that I/We have carefully read all the conditions of tender of Haryana Medical Services

Corporation Limited, Panchkula, for the tenders floated for empanelment of analytical

testing laboratories for the analysis of drugs /surgicals / sutures etc. for the tender period of

two years from the date of acceptance and abide by all conditions set forth therein.

I/We further declare that I/We posses valid License bearing No._______________________

valid upto__________________

I/We further declare that I/We are not supplier of medicines and consumables to any Govt.

in India.

I we further declare that our above firm has not been convicted /blacklisted.

That there are no Civil or Criminal cases pending against the above company in Court of

Law.

That what is stated above by me is true and correct to the best of my knowledge and belief.

Signature :

Date :

Name of the Lab :

Office Seal :

ATTESTED BY NOTARY PUBLIC

Page 93: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 93 of 95

ANNEXURE – X

Ref. Clause No: 4(k)

DETAILS OF LABORATORY

Name of the Drug Testing Laboratory& Full Address:

Phone No:

Fax:

E-mail:

Branches & their Address:

Date of Inception:

Approval No.& Date :

Issued by:

Valid up to:

Details of manufacturing activity if any:

Name of the authorized signatory:

Specimen Signature of the authorized

Signatory:

Specimen Signature of the officer who

is authorized to sign the test reports :

Page 94: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 94 of 95

ANNEXURE XI

Ref. Clause No: 4 (m)

PROFORMA FOR GIVING INFORMATION REGARDING CAPACITY OF ANALYSIS

Name of the Laboratory : ____________________________________

Address : ____________________________________

____________________________________

Types of Samples Total capacity How much samples will be

To be Analys ed of tests/month tested for HMSCL /month

01. Tab. / Cap. / Pessaries

02. Injectable

03. Liquid Orals

04. Ointments / Creams / Gels

05. Others (Drugs)

06. Surgicals (Specify item names)

07. Sutures (Specify types)

Signature :

Date :

Name of the Lab :

Office Seal :

Page 95: NIT-13 - haryanahealth.nic.inharyanahealth.nic.in/WriteReadData/tender/labtenderdocument.pdf · & local anaesthesia Injection 0.5%, 5ml amp. 10 Bupivaccine heavy 5 mg with Dextrose

Page 95 of 95

ANNEXURE XII

Ref. Clause No: 4 (n)

List of clientele of the laboratory for whom analysis has been performed in the previous year

duly certified by Charted Accountant.